###begin article-title 0
###xml 74 82 <span type="species:ncbi:9606">Patients</span>
S-100B Concentrations Predict Disease-Free Survival in Stage III Melanoma Patients
###end article-title 0
###begin title 1
Background
###end title 1
###begin p 2
###xml 49 57 <span type="species:ncbi:9606">patients</span>
Elevation of the tumor marker S-100B in melanoma patients is a highly specific indicator of recurrence.
###end p 2
###begin title 3
Materials and methods
###end title 3
###begin p 4
###xml 337 338 337 338 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">d</italic>
###xml 86 94 <span type="species:ncbi:9606">patients</span>
The role of S-100B in disease-free survival (DFS) was evaluated in stage III melanoma patients (staged with fluorodeoxyglucose positron emission tomography [FDG-PET] and computed tomography [CT]) with palpable lymph node metastases who underwent therapeutic lymph node dissection. S-100B and LDH were measured on the day before surgery (d = -1) and on days 1, 2, and 7 postoperatively. Multivariate logistic regression was used to study factors associated with preoperative elevation of S-100B. Univariate (log-rank test) and multivariate (Cox regression) survival analyses were performed to identify factors associated with DFS.
###end p 4
###begin title 5
Results
###end title 5
###begin p 6
###xml 379 380 379 380 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 494 495 494 495 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 26 34 <span type="species:ncbi:9606">patients</span>
###xml 172 180 <span type="species:ncbi:9606">patients</span>
###xml 210 218 <span type="species:ncbi:9606">patients</span>
Between 2004 and 2008, 56 patients (median age 57, range 24-93) years, 27 males (48%) and 29 females (52%) entered the study. Preoperative S-100B elevation was found in 27 patients (48%) and elevated LDH in 20 patients (36%). No association was found between these two markers at any time. Multivariate analysis showed that elevated S-100B preoperatively (hazard ratio [HR] 2.7, P = .03) was associated with DFS. S-100B elevation was associated with increased tumor size (odds ratio [OR] 3.40; P = .03).
###end p 6
###begin title 7
Conclusion
###end title 7
###begin p 8
###xml 34 42 <span type="species:ncbi:9606">patients</span>
###xml 263 271 <span type="species:ncbi:9606">patients</span>
Elevated S-100B preoperatively in patients with optimally staged clinical stage III melanoma is associated with decreased disease-free survival. S100-B could be used as a prognostic marker in the stratification of new adjuvant trials to select stage III melanoma patients for adjuvant systematic treatment.
###end p 8
###begin p 9
###xml 184 185 184 185 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR1">1</xref>
###xml 239 240 239 240 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR2">2</xref>
###xml 432 433 432 433 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR3">3</xref>
###xml 653 654 653 654 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR1">1</xref>
###xml 141 144 <span type="species:ncbi:9606">men</span>
###xml 178 183 <span type="species:ncbi:9606">women</span>
###xml 203 211 <span type="species:ncbi:9606">patients</span>
###xml 286 294 <span type="species:ncbi:9606">patients</span>
###xml 571 574 <span type="species:ncbi:9606">men</span>
###xml 606 611 <span type="species:ncbi:9606">women</span>
The incidence of melanoma is still increasing in the Netherlands. Between 1989 and 2003, the incidence increased from 9.5 to 13.7/100,000 in men and from 13.4 to 18.5/100,000 in women.1 About 90% of the patients had stage I or II melanoma.2 After surgical treatment, 20-28% of melanoma patients present with locoregional recurrence or regional dermal metastases, 26-60% with regional recurrences, and 15-50% with distant metastases.3 Despite improved public awareness as well as early diagnosis and treatment, mortality from melanoma increased from 2.5 to 3.6/100,000 in men and from 2.0 to 2.4/100,000 in women in the Netherlands between 1989 and 2003.1
###end p 9
###begin p 10
###xml 276 277 276 277 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR4">4</xref>
###xml 399 400 399 400 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR5">5</xref>
###xml 657 658 657 658 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR6">6</xref>
###xml 659 660 659 660 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR7">7</xref>
###xml 799 800 799 800 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR8">8</xref>
###xml 952 953 952 953 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR6">6</xref>
###xml 954 955 954 955 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR7">7</xref>
###xml 78 86 <span type="species:ncbi:9606">patients</span>
###xml 281 289 <span type="species:ncbi:9606">patients</span>
###xml 540 548 <span type="species:ncbi:9606">patients</span>
###xml 625 633 <span type="species:ncbi:9606">patients</span>
###xml 724 732 <span type="species:ncbi:9606">patients</span>
###xml 905 913 <span type="species:ncbi:9606">patients</span>
It is impossible to predict the metastatic behavior of melanoma in individual patients. At present, the Multicentre Selective Lymphadenectomy Trial (MSLT II) is investigating whether sentinel lymph node biopsy reduces the risk of locoregional metastases and improves survival.4 In patients with clinical stage III melanoma (palpable lymph node metastases), 5-year survival varied between 26 and 67%.5 Recent staging studies with whole-body fluorodeoxyglucose positron emission tomography (FDG-PET) and/or spiral computed tomography (CT) in patients with clinical stage III melanoma have shown that about one quarter of these patients had distant metastases.6,7 Furthermore, the uptake of FDG in the lymph node metastases in patients with clinical stage III melanoma proved to be of prognostic value.8 FDG-PET or spiral CT improved the staging of clinical stage III melanoma and led to better selection of patients for therapeutic lymph node dissection.6,7
###end p 10
###begin p 11
###xml 151 152 151 152 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR9">9</xref>
###xml 153 155 153 155 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR12">12</xref>
###xml 237 239 237 239 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR13">13</xref>
###xml 354 356 354 356 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR14">14</xref>
###xml 357 359 357 359 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR15">15</xref>
###xml 220 228 <span type="species:ncbi:9606">patients</span>
Serum lactate dehydrogenase (LDH) had high specificity for melanoma, but low sensitivity. It was an independent prognostic factor in stage IV melanoma.9-12 Increased S-100B concentrations were first detected in melanoma patients in 1980.13 Later, S-100B was found to be a serological tumor marker for melanoma and is mostly increased in stage III and IV.14,15
###end p 11
###begin p 12
###xml 377 379 349 351 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR15">15</xref>
###xml 547 549 519 521 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR16">16</xref>
S-100B is a 21 kilodalton (kDa) protein that was first isolated from the central nervous system in vertebrates. The name is derived from its 100% solvency in saturated ammonium sulfate with neutral pH. It has calcium-binding properties and as a dimer, consists of two isomers alpha and beta. All possible combinations can occur (S-100alphaalpha, S-100alphabeta, S-100betabeta).15 The S-100B protein is of neuroectodermal and mesodermal origin and is expressed in various parts of the body. S-100B is chiefly found in glial cells and Schwann cells.16 Serum S-100B can be measured with an immunoradiometric assay (Sangtec 100 IRMA/RIA assay) or with an immunoluminometric assay (LIA Mat Sangtec 100).
###end p 12
###begin p 13
###xml 153 161 <span type="species:ncbi:9606">patients</span>
This study addressed the question whether the perioperative measurement of the tumor markers S-100B has prognostic value in FDG-PET and spiral CT staged patients with stage III melanoma who are selected for therapeutic lymph node dissection.
###end p 13
###begin title 14
Materials and Methods
###end title 14
###begin title 15
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients
###end title 15
###begin p 16
###xml 681 683 677 679 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR17">17</xref>
###xml 684 686 680 682 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR18">18</xref>
###xml 9 17 <span type="species:ncbi:9606">patients</span>
###xml 320 328 <span type="species:ncbi:9606">patients</span>
###xml 333 341 <span type="species:ncbi:9606">patients</span>
###xml 408 416 <span type="species:ncbi:9606">patients</span>
Melanoma patients, earlier staged AJCC I and II, now presenting with clinically and cytologically proven regional nodal metastases of melanoma (AJCC stage IIIb and IIIc) were staged with whole-body FDG-PET (Siemens ECAT EXACT HR + scanner) and with 64-slice spiral CT (Siemens Somatom Sensation). Sentinel node positive patients and patients with regional dermal metastases were excluded for this study. The patients whose test results were negative for distant metastases were eligible for therapeutic lymph node dissection with curative intent. Nodal metastases of >/= 3 cm and/or >/= 3 positive lymph nodes and/or extra nodal growth received adjuvant radiotherapy (20 x 2.4 Gy).17,18 LDH and S-100B were measured preoperative (day -1) and postoperative days 1, 2, and 7. The study was approved by the Medical Ethical Committee of the UMCG.
###end p 16
###begin title 17
Methods
###end title 17
###begin p 18
LDH was analyzed routinely by means of Roche Modular (Hitachi) with an enzymatic activity measurement; normal values of LDH were considered to be <250 U/L. Concentrations of S-100B were measured using Sangtec 100 immunoassay on the Advantage (Nichols).
###end p 18
###begin p 19
###xml 47 49 47 49 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR19">19</xref>
The S-100B half-life is estimated to be 30 min.19 Approximately 10 times the half-life after lymph node dissection, S-100B values should reduce to the minimum possible. When tumor cells are still present the release of S-100B will continue or may even increase. Therefore, S-100B levels were measured on days -1, 1, 2, and 7.
###end p 19
###begin p 20
###xml 312 315 <span type="species:ncbi:9606">men</span>
###xml 320 325 <span type="species:ncbi:9606">women</span>
Levels were calculated on the basis of a calibration curve and checked against internal standards with a known concentration of S-100B. In this assay, a cut-off point of 0.15 g/L was set. The reference values for the S-100B assay (Liason Sangtec 100) were established by analysis of S-100B values of 120 healthy men and women according to the CLSI C28A2 guideline. Concentrations within this range were considered to be normal, whereas concentration above this range were considered to be elevated. A postoperative increase of S-100B was defined as any increase on the postoperative days 1, 2, or 7 (day 1 as baseline value, elevation on day 2 compared with day 1, and/ or elevation on day 7 compared with day 2).
###end p 20
###begin title 21
Statistics
###end title 21
###begin p 22
Data were analyzed with STATA version 10.0. Logistic regression analysis was used to assess factors associated with elevated S-100B concentrations. Factors associated with disease-free survival (DFS) were analyzed with standard univariate (log-rank test) and multivariate (Cox proportions hazard) survival methods.
###end p 22
###begin title 23
Results
###end title 23
###begin title 24
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients
###end title 24
###begin p 25
###xml 185 186 185 186 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab1" ref-type="table">1</xref>
###xml 529 530 529 530 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 538 539 538 539 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 547 548 547 548 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 560 561 560 561 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 712 719 712 719 <label xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Table&#160;1</label>
###xml 719 773 719 773 <p xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" textid="26">Characteristics of 56 AJCC stage III melanoma patients</p>
###xml 719 773 719 773 <caption xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="26">Characteristics of 56 AJCC stage III melanoma patients</p></caption>
###xml 773 781 773 781 <th xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Variable</th>
###xml 781 789 781 789 <th xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Patients</th>
###xml 789 799 789 799 <th xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Percentage</th>
###xml 773 799 773 799 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left">Variable</th><th align="left">Patients</th><th align="left">Percentage</th></tr>
###xml 773 799 773 799 <thead xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th align="left">Variable</th><th align="left">Patients</th><th align="left">Percentage</th></tr></thead>
###xml 799 805 799 805 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Gender</italic>
###xml 799 805 799 805 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="3"><italic>Gender</italic></td>
###xml 799 805 799 805 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left" colspan="3"><italic>Gender</italic></td></tr>
###xml 805 809 805 809 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Male</td>
###xml 809 811 809 811 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">27</td>
###xml 811 815 811 815 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">48.2</td>
###xml 805 815 805 815 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Male</td><td char="." align="char">27</td><td char="." align="char">48.2</td></tr>
###xml 815 821 815 821 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Female</td>
###xml 821 823 821 823 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">29</td>
###xml 823 827 823 827 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">51.8</td>
###xml 815 827 815 827 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Female</td><td char="." align="char">29</td><td char="." align="char">51.8</td></tr>
###xml 827 845 827 845 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Median age (years)</italic>
###xml 827 845 827 845 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><italic>Median age (years)</italic></td>
###xml 845 849 845 849 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">57.0</td>
###xml 849 849 849 849 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 827 849 827 849 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left"><italic>Median age (years)</italic></td><td char="." align="char">57.0</td><td align="left"/></tr>
###xml 849 875 849 875 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Localization primary tumor</italic>
###xml 849 875 849 875 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="3"><italic>Localization primary tumor</italic></td>
###xml 849 875 849 875 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left" colspan="3"><italic>Localization primary tumor</italic></td></tr>
###xml 875 880 875 880 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Trunk</td>
###xml 880 882 880 882 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">24</td>
###xml 882 886 882 886 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">42.8</td>
###xml 875 886 875 886 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Trunk</td><td char="." align="char">24</td><td char="." align="char">42.8</td></tr>
###xml 886 899 886 899 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Head and neck</td>
###xml 899 900 899 900 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">3</td>
###xml 900 903 900 903 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">5.3</td>
###xml 886 903 886 903 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Head and neck</td><td char="." align="char">3</td><td char="." align="char">5.3</td></tr>
###xml 903 920 903 920 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Upper extremities</td>
###xml 920 921 920 921 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">7</td>
###xml 921 925 921 925 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">12.5</td>
###xml 903 925 903 925 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Upper extremities</td><td char="." align="char">7</td><td char="." align="char">12.5</td></tr>
###xml 925 942 925 942 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Lower extremities</td>
###xml 942 944 942 944 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">22</td>
###xml 944 948 944 948 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">55.8</td>
###xml 925 948 925 948 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Lower extremities</td><td char="." align="char">22</td><td char="." align="char">55.8</td></tr>
###xml 948 979 948 979 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Breslow thickness primary tumor</italic>
###xml 948 979 948 979 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="3"><italic>Breslow thickness primary tumor</italic></td>
###xml 948 979 948 979 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left" colspan="3"><italic>Breslow thickness primary tumor</italic></td></tr>
###xml 979 991 979 991 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">T1 (&lt;1.0&#160;mm)</td>
###xml 991 992 991 992 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">7</td>
###xml 992 996 992 996 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">12.5</td>
###xml 979 996 979 996 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">T1 (&lt;1.0&#160;mm)</td><td char="." align="char">7</td><td char="." align="char">12.5</td></tr>
###xml 996 1011 996 1011 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">T2 (1.0&#8211;2.0&#160;mm)</td>
###xml 1011 1013 1011 1013 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">20</td>
###xml 1013 1017 1013 1017 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">35.7</td>
###xml 996 1017 996 1017 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">T2 (1.0&#8211;2.0&#160;mm)</td><td char="." align="char">20</td><td char="." align="char">35.7</td></tr>
###xml 1017 1032 1017 1032 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">T3 (2.0&#8211;4.0&#160;mm)</td>
###xml 1032 1034 1032 1034 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">21</td>
###xml 1034 1038 1034 1038 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">37.5</td>
###xml 1017 1038 1017 1038 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">T3 (2.0&#8211;4.0&#160;mm)</td><td char="." align="char">21</td><td char="." align="char">37.5</td></tr>
###xml 1038 1050 1038 1050 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">T4 (&gt;4.0&#160;mm)</td>
###xml 1050 1051 1050 1051 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">8</td>
###xml 1051 1055 1051 1055 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">14.2</td>
###xml 1038 1055 1038 1055 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">T4 (&gt;4.0&#160;mm)</td><td char="." align="char">8</td><td char="." align="char">14.2</td></tr>
###xml 1055 1080 1055 1080 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Clark level primary tumor</italic>
###xml 1055 1080 1055 1080 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="3"><italic>Clark level primary tumor</italic></td>
###xml 1055 1080 1055 1080 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left" colspan="3"><italic>Clark level primary tumor</italic></td></tr>
###xml 1080 1083 1080 1083 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1&#8211;3</td>
###xml 1083 1085 1083 1085 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">24</td>
###xml 1085 1089 1085 1089 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">42.6</td>
###xml 1080 1089 1080 1089 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">1&#8211;3</td><td char="." align="char">24</td><td char="." align="char">42.6</td></tr>
###xml 1089 1092 1089 1092 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">4&#8211;5</td>
###xml 1092 1094 1092 1094 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">31</td>
###xml 1094 1098 1094 1098 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">55.4</td>
###xml 1089 1098 1089 1098 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">4&#8211;5</td><td char="." align="char">31</td><td char="." align="char">55.4</td></tr>
###xml 1098 1105 1098 1105 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Unknown</td>
###xml 1105 1106 1105 1106 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">1</td>
###xml 1106 1109 1106 1109 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">1.8</td>
###xml 1098 1109 1098 1109 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Unknown</td><td char="." align="char">1</td><td char="." align="char">1.8</td></tr>
###xml 1109 1133 1109 1133 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Localization lymph nodes</italic>
###xml 1109 1133 1109 1133 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="3"><italic>Localization lymph nodes</italic></td>
###xml 1109 1133 1109 1133 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left" colspan="3"><italic>Localization lymph nodes</italic></td></tr>
###xml 1133 1137 1133 1137 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Neck</td>
###xml 1137 1138 1137 1138 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">6</td>
###xml 1138 1142 1138 1142 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">10.7</td>
###xml 1133 1142 1133 1142 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Neck</td><td char="." align="char">6</td><td char="." align="char">10.7</td></tr>
###xml 1142 1148 1142 1148 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Axilla</td>
###xml 1148 1150 1148 1150 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">20</td>
###xml 1150 1154 1150 1154 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">35.7</td>
###xml 1142 1154 1142 1154 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Axilla</td><td char="." align="char">20</td><td char="." align="char">35.7</td></tr>
###xml 1154 1159 1154 1159 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Groin</td>
###xml 1159 1161 1159 1161 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">30</td>
###xml 1161 1165 1161 1165 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">53.5</td>
###xml 1154 1165 1154 1165 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Groin</td><td char="." align="char">30</td><td char="." align="char">53.5</td></tr>
###xml 1165 1178 1165 1178 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Nodes removed</italic>
###xml 1165 1178 1165 1178 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="3"><italic>Nodes removed</italic></td>
###xml 1165 1178 1165 1178 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left" colspan="3"><italic>Nodes removed</italic></td></tr>
###xml 1178 1181 1178 1181 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&lt;15</td>
###xml 1181 1183 1181 1183 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">27</td>
###xml 1183 1187 1183 1187 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">48.2</td>
###xml 1178 1187 1178 1187 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&lt;15</td><td char="." align="char">27</td><td char="." align="char">48.2</td></tr>
###xml 1187 1192 1187 1190 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8805;15</td>
###xml 1192 1194 1190 1192 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">29</td>
###xml 1194 1198 1192 1196 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">52.8</td>
###xml 1187 1198 1187 1196 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#8805;15</td><td char="." align="char">29</td><td char="." align="char">52.8</td></tr>
###xml 1198 1212 1196 1210 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Positive nodes</italic>
###xml 1198 1212 1196 1210 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="3"><italic>Positive nodes</italic></td>
###xml 1198 1212 1196 1210 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left" colspan="3"><italic>Positive nodes</italic></td></tr>
###xml 1212 1214 1210 1212 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&lt;2</td>
###xml 1214 1216 1212 1214 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">36</td>
###xml 1216 1220 1214 1218 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">64.3</td>
###xml 1212 1220 1210 1218 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&lt;2</td><td char="." align="char">36</td><td char="." align="char">64.3</td></tr>
###xml 1220 1224 1218 1220 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8805;2</td>
###xml 1224 1226 1220 1222 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">20</td>
###xml 1226 1230 1222 1226 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">35.7</td>
###xml 1220 1230 1218 1226 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#8805;2</td><td char="." align="char">20</td><td char="." align="char">35.7</td></tr>
###xml 1230 1247 1226 1243 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Extranodal growth</italic>
###xml 1230 1247 1226 1243 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="3"><italic>Extranodal growth</italic></td>
###xml 1230 1247 1226 1243 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left" colspan="3"><italic>Extranodal growth</italic></td></tr>
###xml 1247 1250 1243 1246 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Yes</td>
###xml 1250 1252 1246 1248 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">24</td>
###xml 1252 1256 1248 1252 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">42.6</td>
###xml 1247 1256 1243 1252 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Yes</td><td char="." align="char">24</td><td char="." align="char">42.6</td></tr>
###xml 1256 1258 1252 1254 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">No</td>
###xml 1258 1260 1254 1256 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">42</td>
###xml 1260 1264 1256 1260 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">56.4</td>
###xml 1256 1264 1252 1260 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">No</td><td char="." align="char">42</td><td char="." align="char">56.4</td></tr>
###xml 1264 1279 1260 1275 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Lymph node size</italic>
###xml 1264 1279 1260 1275 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="3"><italic>Lymph node size</italic></td>
###xml 1264 1279 1260 1275 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left" colspan="3"><italic>Lymph node size</italic></td></tr>
###xml 1279 1284 1275 1280 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&lt;3&#160;cm</td>
###xml 1284 1286 1280 1282 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">28</td>
###xml 1286 1290 1282 1286 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">50.0</td>
###xml 1279 1290 1275 1286 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&lt;3&#160;cm</td><td char="." align="char">28</td><td char="." align="char">50.0</td></tr>
###xml 1290 1297 1286 1291 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8805;3&#160;cm</td>
###xml 1297 1299 1291 1293 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">28</td>
###xml 1299 1303 1293 1297 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">50.0</td>
###xml 1290 1303 1286 1297 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#8805;3&#160;cm</td><td char="." align="char">28</td><td char="." align="char">50.0</td></tr>
###xml 1303 1327 1297 1321 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Ulceration primary tumor</italic>
###xml 1303 1327 1297 1321 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="3"><italic>Ulceration primary tumor</italic></td>
###xml 1303 1327 1297 1321 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left" colspan="3"><italic>Ulceration primary tumor</italic></td></tr>
###xml 1327 1330 1321 1324 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Yes</td>
###xml 1330 1332 1324 1326 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">13</td>
###xml 1332 1336 1326 1330 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">23.2</td>
###xml 1327 1336 1321 1330 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Yes</td><td char="." align="char">13</td><td char="." align="char">23.2</td></tr>
###xml 1336 1338 1330 1332 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">No</td>
###xml 1338 1340 1332 1334 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">43</td>
###xml 1340 1344 1334 1338 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">76.8</td>
###xml 1336 1344 1330 1338 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">No</td><td char="." align="char">43</td><td char="." align="char">76.8</td></tr>
###xml 1344 1354 1338 1348 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">AJCC stage</italic>
###xml 1344 1354 1338 1348 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="3"><italic>AJCC stage</italic></td>
###xml 1344 1354 1338 1348 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left" colspan="3"><italic>AJCC stage</italic></td></tr>
###xml 1354 1358 1348 1352 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">IIIa</td>
###xml 1358 1359 1352 1353 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0</td>
###xml 1359 1362 1353 1356 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.0</td>
###xml 1354 1362 1348 1356 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">IIIa</td><td char="." align="char">0</td><td char="." align="char">0.0</td></tr>
###xml 1362 1366 1356 1360 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">IIIb</td>
###xml 1366 1368 1360 1362 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">30</td>
###xml 1368 1372 1362 1366 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">53.6</td>
###xml 1362 1372 1356 1366 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">IIIb</td><td char="." align="char">30</td><td char="." align="char">53.6</td></tr>
###xml 1372 1376 1366 1370 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">IIIc</td>
###xml 1376 1378 1370 1372 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">26</td>
###xml 1378 1382 1372 1376 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">46.4</td>
###xml 1372 1382 1366 1376 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">IIIc</td><td char="." align="char">26</td><td char="." align="char">46.4</td></tr>
###xml 799 1382 799 1376 <tbody xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td align="left" colspan="3"><italic>Gender</italic></td></tr><tr><td align="left">Male</td><td char="." align="char">27</td><td char="." align="char">48.2</td></tr><tr><td align="left">Female</td><td char="." align="char">29</td><td char="." align="char">51.8</td></tr><tr><td align="left"><italic>Median age (years)</italic></td><td char="." align="char">57.0</td><td align="left"/></tr><tr><td align="left" colspan="3"><italic>Localization primary tumor</italic></td></tr><tr><td align="left">Trunk</td><td char="." align="char">24</td><td char="." align="char">42.8</td></tr><tr><td align="left">Head and neck</td><td char="." align="char">3</td><td char="." align="char">5.3</td></tr><tr><td align="left">Upper extremities</td><td char="." align="char">7</td><td char="." align="char">12.5</td></tr><tr><td align="left">Lower extremities</td><td char="." align="char">22</td><td char="." align="char">55.8</td></tr><tr><td align="left" colspan="3"><italic>Breslow thickness primary tumor</italic></td></tr><tr><td align="left">T1 (&lt;1.0&#160;mm)</td><td char="." align="char">7</td><td char="." align="char">12.5</td></tr><tr><td align="left">T2 (1.0&#8211;2.0&#160;mm)</td><td char="." align="char">20</td><td char="." align="char">35.7</td></tr><tr><td align="left">T3 (2.0&#8211;4.0&#160;mm)</td><td char="." align="char">21</td><td char="." align="char">37.5</td></tr><tr><td align="left">T4 (&gt;4.0&#160;mm)</td><td char="." align="char">8</td><td char="." align="char">14.2</td></tr><tr><td align="left" colspan="3"><italic>Clark level primary tumor</italic></td></tr><tr><td align="left">1&#8211;3</td><td char="." align="char">24</td><td char="." align="char">42.6</td></tr><tr><td align="left">4&#8211;5</td><td char="." align="char">31</td><td char="." align="char">55.4</td></tr><tr><td align="left">Unknown</td><td char="." align="char">1</td><td char="." align="char">1.8</td></tr><tr><td align="left" colspan="3"><italic>Localization lymph nodes</italic></td></tr><tr><td align="left">Neck</td><td char="." align="char">6</td><td char="." align="char">10.7</td></tr><tr><td align="left">Axilla</td><td char="." align="char">20</td><td char="." align="char">35.7</td></tr><tr><td align="left">Groin</td><td char="." align="char">30</td><td char="." align="char">53.5</td></tr><tr><td align="left" colspan="3"><italic>Nodes removed</italic></td></tr><tr><td align="left">&lt;15</td><td char="." align="char">27</td><td char="." align="char">48.2</td></tr><tr><td align="left">&#8805;15</td><td char="." align="char">29</td><td char="." align="char">52.8</td></tr><tr><td align="left" colspan="3"><italic>Positive nodes</italic></td></tr><tr><td align="left">&lt;2</td><td char="." align="char">36</td><td char="." align="char">64.3</td></tr><tr><td align="left">&#8805;2</td><td char="." align="char">20</td><td char="." align="char">35.7</td></tr><tr><td align="left" colspan="3"><italic>Extranodal growth</italic></td></tr><tr><td align="left">Yes</td><td char="." align="char">24</td><td char="." align="char">42.6</td></tr><tr><td align="left">No</td><td char="." align="char">42</td><td char="." align="char">56.4</td></tr><tr><td align="left" colspan="3"><italic>Lymph node size</italic></td></tr><tr><td align="left">&lt;3&#160;cm</td><td char="." align="char">28</td><td char="." align="char">50.0</td></tr><tr><td align="left">&#8805;3&#160;cm</td><td char="." align="char">28</td><td char="." align="char">50.0</td></tr><tr><td align="left" colspan="3"><italic>Ulceration primary tumor</italic></td></tr><tr><td align="left">Yes</td><td char="." align="char">13</td><td char="." align="char">23.2</td></tr><tr><td align="left">No</td><td char="." align="char">43</td><td char="." align="char">76.8</td></tr><tr><td align="left" colspan="3"><italic>AJCC stage</italic></td></tr><tr><td align="left">IIIa</td><td char="." align="char">0</td><td char="." align="char">0.0</td></tr><tr><td align="left">IIIb</td><td char="." align="char">30</td><td char="." align="char">53.6</td></tr><tr><td align="left">IIIc</td><td char="." align="char">26</td><td char="." align="char">46.4</td></tr></tbody>
###xml 773 1382 773 1376 <table xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th align="left">Variable</th><th align="left">Patients</th><th align="left">Percentage</th></tr></thead><tbody><tr><td align="left" colspan="3"><italic>Gender</italic></td></tr><tr><td align="left">Male</td><td char="." align="char">27</td><td char="." align="char">48.2</td></tr><tr><td align="left">Female</td><td char="." align="char">29</td><td char="." align="char">51.8</td></tr><tr><td align="left"><italic>Median age (years)</italic></td><td char="." align="char">57.0</td><td align="left"/></tr><tr><td align="left" colspan="3"><italic>Localization primary tumor</italic></td></tr><tr><td align="left">Trunk</td><td char="." align="char">24</td><td char="." align="char">42.8</td></tr><tr><td align="left">Head and neck</td><td char="." align="char">3</td><td char="." align="char">5.3</td></tr><tr><td align="left">Upper extremities</td><td char="." align="char">7</td><td char="." align="char">12.5</td></tr><tr><td align="left">Lower extremities</td><td char="." align="char">22</td><td char="." align="char">55.8</td></tr><tr><td align="left" colspan="3"><italic>Breslow thickness primary tumor</italic></td></tr><tr><td align="left">T1 (&lt;1.0&#160;mm)</td><td char="." align="char">7</td><td char="." align="char">12.5</td></tr><tr><td align="left">T2 (1.0&#8211;2.0&#160;mm)</td><td char="." align="char">20</td><td char="." align="char">35.7</td></tr><tr><td align="left">T3 (2.0&#8211;4.0&#160;mm)</td><td char="." align="char">21</td><td char="." align="char">37.5</td></tr><tr><td align="left">T4 (&gt;4.0&#160;mm)</td><td char="." align="char">8</td><td char="." align="char">14.2</td></tr><tr><td align="left" colspan="3"><italic>Clark level primary tumor</italic></td></tr><tr><td align="left">1&#8211;3</td><td char="." align="char">24</td><td char="." align="char">42.6</td></tr><tr><td align="left">4&#8211;5</td><td char="." align="char">31</td><td char="." align="char">55.4</td></tr><tr><td align="left">Unknown</td><td char="." align="char">1</td><td char="." align="char">1.8</td></tr><tr><td align="left" colspan="3"><italic>Localization lymph nodes</italic></td></tr><tr><td align="left">Neck</td><td char="." align="char">6</td><td char="." align="char">10.7</td></tr><tr><td align="left">Axilla</td><td char="." align="char">20</td><td char="." align="char">35.7</td></tr><tr><td align="left">Groin</td><td char="." align="char">30</td><td char="." align="char">53.5</td></tr><tr><td align="left" colspan="3"><italic>Nodes removed</italic></td></tr><tr><td align="left">&lt;15</td><td char="." align="char">27</td><td char="." align="char">48.2</td></tr><tr><td align="left">&#8805;15</td><td char="." align="char">29</td><td char="." align="char">52.8</td></tr><tr><td align="left" colspan="3"><italic>Positive nodes</italic></td></tr><tr><td align="left">&lt;2</td><td char="." align="char">36</td><td char="." align="char">64.3</td></tr><tr><td align="left">&#8805;2</td><td char="." align="char">20</td><td char="." align="char">35.7</td></tr><tr><td align="left" colspan="3"><italic>Extranodal growth</italic></td></tr><tr><td align="left">Yes</td><td char="." align="char">24</td><td char="." align="char">42.6</td></tr><tr><td align="left">No</td><td char="." align="char">42</td><td char="." align="char">56.4</td></tr><tr><td align="left" colspan="3"><italic>Lymph node size</italic></td></tr><tr><td align="left">&lt;3&#160;cm</td><td char="." align="char">28</td><td char="." align="char">50.0</td></tr><tr><td align="left">&#8805;3&#160;cm</td><td char="." align="char">28</td><td char="." align="char">50.0</td></tr><tr><td align="left" colspan="3"><italic>Ulceration primary tumor</italic></td></tr><tr><td align="left">Yes</td><td char="." align="char">13</td><td char="." align="char">23.2</td></tr><tr><td align="left">No</td><td char="." align="char">43</td><td char="." align="char">76.8</td></tr><tr><td align="left" colspan="3"><italic>AJCC stage</italic></td></tr><tr><td align="left">IIIa</td><td char="." align="char">0</td><td char="." align="char">0.0</td></tr><tr><td align="left">IIIb</td><td char="." align="char">30</td><td char="." align="char">53.6</td></tr><tr><td align="left">IIIc</td><td char="." align="char">26</td><td char="." align="char">46.4</td></tr></tbody></table>
###xml 712 1382 712 1376 <table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab1"><label>Table&#160;1</label><caption><p textid="26">Characteristics of 56 AJCC stage III melanoma patients</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Variable</th><th align="left">Patients</th><th align="left">Percentage</th></tr></thead><tbody><tr><td align="left" colspan="3"><italic>Gender</italic></td></tr><tr><td align="left">Male</td><td char="." align="char">27</td><td char="." align="char">48.2</td></tr><tr><td align="left">Female</td><td char="." align="char">29</td><td char="." align="char">51.8</td></tr><tr><td align="left"><italic>Median age (years)</italic></td><td char="." align="char">57.0</td><td align="left"/></tr><tr><td align="left" colspan="3"><italic>Localization primary tumor</italic></td></tr><tr><td align="left">Trunk</td><td char="." align="char">24</td><td char="." align="char">42.8</td></tr><tr><td align="left">Head and neck</td><td char="." align="char">3</td><td char="." align="char">5.3</td></tr><tr><td align="left">Upper extremities</td><td char="." align="char">7</td><td char="." align="char">12.5</td></tr><tr><td align="left">Lower extremities</td><td char="." align="char">22</td><td char="." align="char">55.8</td></tr><tr><td align="left" colspan="3"><italic>Breslow thickness primary tumor</italic></td></tr><tr><td align="left">T1 (&lt;1.0&#160;mm)</td><td char="." align="char">7</td><td char="." align="char">12.5</td></tr><tr><td align="left">T2 (1.0&#8211;2.0&#160;mm)</td><td char="." align="char">20</td><td char="." align="char">35.7</td></tr><tr><td align="left">T3 (2.0&#8211;4.0&#160;mm)</td><td char="." align="char">21</td><td char="." align="char">37.5</td></tr><tr><td align="left">T4 (&gt;4.0&#160;mm)</td><td char="." align="char">8</td><td char="." align="char">14.2</td></tr><tr><td align="left" colspan="3"><italic>Clark level primary tumor</italic></td></tr><tr><td align="left">1&#8211;3</td><td char="." align="char">24</td><td char="." align="char">42.6</td></tr><tr><td align="left">4&#8211;5</td><td char="." align="char">31</td><td char="." align="char">55.4</td></tr><tr><td align="left">Unknown</td><td char="." align="char">1</td><td char="." align="char">1.8</td></tr><tr><td align="left" colspan="3"><italic>Localization lymph nodes</italic></td></tr><tr><td align="left">Neck</td><td char="." align="char">6</td><td char="." align="char">10.7</td></tr><tr><td align="left">Axilla</td><td char="." align="char">20</td><td char="." align="char">35.7</td></tr><tr><td align="left">Groin</td><td char="." align="char">30</td><td char="." align="char">53.5</td></tr><tr><td align="left" colspan="3"><italic>Nodes removed</italic></td></tr><tr><td align="left">&lt;15</td><td char="." align="char">27</td><td char="." align="char">48.2</td></tr><tr><td align="left">&#8805;15</td><td char="." align="char">29</td><td char="." align="char">52.8</td></tr><tr><td align="left" colspan="3"><italic>Positive nodes</italic></td></tr><tr><td align="left">&lt;2</td><td char="." align="char">36</td><td char="." align="char">64.3</td></tr><tr><td align="left">&#8805;2</td><td char="." align="char">20</td><td char="." align="char">35.7</td></tr><tr><td align="left" colspan="3"><italic>Extranodal growth</italic></td></tr><tr><td align="left">Yes</td><td char="." align="char">24</td><td char="." align="char">42.6</td></tr><tr><td align="left">No</td><td char="." align="char">42</td><td char="." align="char">56.4</td></tr><tr><td align="left" colspan="3"><italic>Lymph node size</italic></td></tr><tr><td align="left">&lt;3&#160;cm</td><td char="." align="char">28</td><td char="." align="char">50.0</td></tr><tr><td align="left">&#8805;3&#160;cm</td><td char="." align="char">28</td><td char="." align="char">50.0</td></tr><tr><td align="left" colspan="3"><italic>Ulceration primary tumor</italic></td></tr><tr><td align="left">Yes</td><td char="." align="char">13</td><td char="." align="char">23.2</td></tr><tr><td align="left">No</td><td char="." align="char">43</td><td char="." align="char">76.8</td></tr><tr><td align="left" colspan="3"><italic>AJCC stage</italic></td></tr><tr><td align="left">IIIa</td><td char="." align="char">0</td><td char="." align="char">0.0</td></tr><tr><td align="left">IIIb</td><td char="." align="char">30</td><td char="." align="char">53.6</td></tr><tr><td align="left">IIIc</td><td char="." align="char">26</td><td char="." align="char">46.4</td></tr></tbody></table></table-wrap>
###xml 52 60 <span type="species:ncbi:9606">patients</span>
###xml 208 216 <span type="species:ncbi:9606">patients</span>
###xml 268 276 <span type="species:ncbi:9606">patients</span>
###xml 652 660 <span type="species:ncbi:9606">patients</span>
###xml 697 705 <span type="species:ncbi:9606">patients</span>
In the period from January 2004 to January 2008, 56 patients (27 males [48%] and 29 females [52%]), median age 57 (range 24-93) years underwent therapeutic lymph node dissection (Table 1). Preoperatively, 27 patients had elevated S-100B concentrations (48%), while 20 patients had increased LDH levels (36%). The range on day -1, 1, 2, and 7 for S-100B was 0.03-23.3, 0.02-1.5, 0.03-0.82, 0.01-0.22 and for LDH 109-428, 106-816, 108-335, 115-802. No associations were found between S-100B and LDH levels on days -1, 1, 2, and 7 (P = .45, P = .87, P = .84, and P = .90, respectively). The S-100B concentration normalized postoperatively in 22 of the 27 patients (81.4%) and the LDH in 18 of the 20 patients (90%).Table 1Characteristics of 56 AJCC stage III melanoma patientsVariablePatientsPercentageGenderMale2748.2Female2951.8Median age (years)57.0Localization primary tumorTrunk2442.8Head and neck35.3Upper extremities712.5Lower extremities2255.8Breslow thickness primary tumorT1 (<1.0 mm)712.5T2 (1.0-2.0 mm)2035.7T3 (2.0-4.0 mm)2137.5T4 (>4.0 mm)814.2Clark level primary tumor1-32442.64-53155.4Unknown11.8Localization lymph nodesNeck610.7Axilla2035.7Groin3053.5Nodes removed<152748.2>/=152952.8Positive nodes<23664.3>/=22035.7Extranodal growthYes2442.6No4256.4Lymph node size<3 cm2850.0>/=3 cm2850.0Ulceration primary tumorYes1323.2No4376.8AJCC stageIIIa00.0IIIb3053.6IIIc2646.4
###end p 25
###begin p 26
###xml 46 54 <span type="species:ncbi:9606">patients</span>
Characteristics of 56 AJCC stage III melanoma patients
###end p 26
###begin p 27
###xml 98 99 98 99 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 158 159 158 159 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 201 202 201 202 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 215 216 215 216 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 235 236 235 236 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 250 251 250 251 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab2" ref-type="table">2</xref>
###xml 253 260 253 260 <label xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Table&#160;2</label>
###xml 260 351 260 351 <p xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" textid="28">Logistic regression analysis on elevated preoperative S-100B in stage III melanoma patients</p>
###xml 260 351 260 351 <caption xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="28">Logistic regression analysis on elevated preoperative S-100B in stage III melanoma patients</p></caption>
###xml 351 359 351 359 <th xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Variable</th>
###xml 359 391 359 391 <th xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Elevated preoperative S-100B (%)</th>
###xml 391 393 391 393 <th xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">OR</th>
###xml 393 394 393 394 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 393 400 393 400 <th xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><italic>P</italic> value</th>
###xml 351 400 351 400 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left">Variable</th><th align="left">Elevated preoperative S-100B (%)</th><th align="left">OR</th><th align="left"><italic>P</italic> value</th></tr>
###xml 351 400 351 400 <thead xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th align="left">Variable</th><th align="left">Elevated preoperative S-100B (%)</th><th align="left">OR</th><th align="left"><italic>P</italic> value</th></tr></thead>
###xml 400 403 400 403 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Sex</italic>
###xml 400 403 400 403 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="4"><italic>Sex</italic></td>
###xml 400 403 400 403 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left" colspan="4"><italic>Sex</italic></td></tr>
###xml 403 407 403 407 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Male</td>
###xml 407 411 407 411 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">51.9</td>
###xml 411 414 411 414 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Ref</td>
###xml 414 414 414 414 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"/>
###xml 403 414 403 414 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Male</td><td char="." align="char">51.9</td><td align="left">Ref</td><td char="." align="char"/></tr>
###xml 414 420 414 420 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Female</td>
###xml 420 424 420 424 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">44.8</td>
###xml 424 437 424 437 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.8 (0.3&#8211;2.2)</td>
###xml 437 439 437 439 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">.6</td>
###xml 414 439 414 439 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Female</td><td char="." align="char">44.8</td><td align="left">0.8 (0.3&#8211;2.2)</td><td char="." align="char">.6</td></tr>
###xml 439 442 439 442 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Age</italic>
###xml 439 442 439 442 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="4"><italic>Age</italic></td>
###xml 439 442 439 442 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left" colspan="4"><italic>Age</italic></td></tr>
###xml 442 451 442 451 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&lt;55&#160;years</td>
###xml 451 455 451 455 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">44.0</td>
###xml 455 458 455 458 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Ref</td>
###xml 458 458 458 458 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"/>
###xml 442 458 442 458 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&lt;55&#160;years</td><td char="." align="char">44.0</td><td align="left">Ref</td><td char="." align="char"/></tr>
###xml 458 469 458 467 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8805;55&#160;years</td>
###xml 469 473 467 471 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">51.6</td>
###xml 473 486 471 484 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1.4 (0.5&#8211;3.9)</td>
###xml 486 488 484 486 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">.6</td>
###xml 458 488 458 486 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#8805;55&#160;years</td><td char="." align="char">51.6</td><td align="left">1.4 (0.5&#8211;3.9)</td><td char="." align="char">.6</td></tr>
###xml 488 508 486 506 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Positive lymph nodes</italic>
###xml 488 508 486 506 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="4"><italic>Positive lymph nodes</italic></td>
###xml 488 508 486 506 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left" colspan="4"><italic>Positive lymph nodes</italic></td></tr>
###xml 508 512 506 508 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8804;2</td>
###xml 512 516 508 512 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">44.4</td>
###xml 516 519 512 515 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Ref</td>
###xml 519 519 515 515 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"/>
###xml 508 519 506 515 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#8804;2</td><td char="." align="char">44.4</td><td align="left">Ref</td><td char="." align="char"/></tr>
###xml 519 521 515 517 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&gt;2</td>
###xml 521 525 517 521 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">55.0</td>
###xml 525 538 521 534 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1.5 (0.5&#8211;4.6)</td>
###xml 538 540 534 536 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">.5</td>
###xml 519 540 515 536 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&gt;2</td><td char="." align="char">55.0</td><td align="left">1.5 (0.5&#8211;4.6)</td><td char="." align="char">.5</td></tr>
###xml 540 557 536 553 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Extranodal growth</italic>
###xml 540 557 536 553 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="4"><italic>Extranodal growth</italic></td>
###xml 540 557 536 553 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left" colspan="4"><italic>Extranodal growth</italic></td></tr>
###xml 557 560 553 556 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Yes</td>
###xml 560 564 556 560 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">52.2</td>
###xml 564 567 560 563 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Ref</td>
###xml 567 567 563 563 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"/>
###xml 557 567 553 563 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Yes</td><td char="." align="char">52.2</td><td align="left">Ref</td><td char="." align="char"/></tr>
###xml 567 569 563 565 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">No</td>
###xml 569 573 565 569 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">48.4</td>
###xml 573 586 569 582 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.9 (0.3&#8211;2.5)</td>
###xml 586 588 582 584 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">.8</td>
###xml 567 588 563 584 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">No</td><td char="." align="char">48.4</td><td align="left">0.9 (0.3&#8211;2.5)</td><td char="." align="char">.8</td></tr>
###xml 588 598 584 594 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Tumor size</italic>
###xml 588 598 584 594 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="4"><italic>Tumor size</italic></td>
###xml 588 598 584 594 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left" colspan="4"><italic>Tumor size</italic></td></tr>
###xml 598 603 594 599 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&lt;3&#160;cm</td>
###xml 603 607 599 603 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">35.7</td>
###xml 607 610 603 606 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Ref</td>
###xml 610 610 606 606 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"/>
###xml 598 610 594 606 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&lt;3&#160;cm</td><td char="." align="char">35.7</td><td align="left">Ref</td><td char="." align="char"/></tr>
###xml 610 617 606 611 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8805;3&#160;cm</td>
###xml 617 621 611 615 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">65.4</td>
###xml 621 635 615 629 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">3.4 (1.1&#8211;10.4)</td>
###xml 635 638 629 632 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">.03</td>
###xml 610 638 606 632 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#8805;3&#160;cm</td><td char="." align="char">65.4</td><td align="left">3.4 (1.1&#8211;10.4)</td><td char="." align="char">.03</td></tr>
###xml 400 638 400 632 <tbody xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td align="left" colspan="4"><italic>Sex</italic></td></tr><tr><td align="left">Male</td><td char="." align="char">51.9</td><td align="left">Ref</td><td char="." align="char"/></tr><tr><td align="left">Female</td><td char="." align="char">44.8</td><td align="left">0.8 (0.3&#8211;2.2)</td><td char="." align="char">.6</td></tr><tr><td align="left" colspan="4"><italic>Age</italic></td></tr><tr><td align="left">&lt;55&#160;years</td><td char="." align="char">44.0</td><td align="left">Ref</td><td char="." align="char"/></tr><tr><td align="left">&#8805;55&#160;years</td><td char="." align="char">51.6</td><td align="left">1.4 (0.5&#8211;3.9)</td><td char="." align="char">.6</td></tr><tr><td align="left" colspan="4"><italic>Positive lymph nodes</italic></td></tr><tr><td align="left">&#8804;2</td><td char="." align="char">44.4</td><td align="left">Ref</td><td char="." align="char"/></tr><tr><td align="left">&gt;2</td><td char="." align="char">55.0</td><td align="left">1.5 (0.5&#8211;4.6)</td><td char="." align="char">.5</td></tr><tr><td align="left" colspan="4"><italic>Extranodal growth</italic></td></tr><tr><td align="left">Yes</td><td char="." align="char">52.2</td><td align="left">Ref</td><td char="." align="char"/></tr><tr><td align="left">No</td><td char="." align="char">48.4</td><td align="left">0.9 (0.3&#8211;2.5)</td><td char="." align="char">.8</td></tr><tr><td align="left" colspan="4"><italic>Tumor size</italic></td></tr><tr><td align="left">&lt;3&#160;cm</td><td char="." align="char">35.7</td><td align="left">Ref</td><td char="." align="char"/></tr><tr><td align="left">&#8805;3&#160;cm</td><td char="." align="char">65.4</td><td align="left">3.4 (1.1&#8211;10.4)</td><td char="." align="char">.03</td></tr></tbody>
###xml 351 638 351 632 <table xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th align="left">Variable</th><th align="left">Elevated preoperative S-100B (%)</th><th align="left">OR</th><th align="left"><italic>P</italic> value</th></tr></thead><tbody><tr><td align="left" colspan="4"><italic>Sex</italic></td></tr><tr><td align="left">Male</td><td char="." align="char">51.9</td><td align="left">Ref</td><td char="." align="char"/></tr><tr><td align="left">Female</td><td char="." align="char">44.8</td><td align="left">0.8 (0.3&#8211;2.2)</td><td char="." align="char">.6</td></tr><tr><td align="left" colspan="4"><italic>Age</italic></td></tr><tr><td align="left">&lt;55&#160;years</td><td char="." align="char">44.0</td><td align="left">Ref</td><td char="." align="char"/></tr><tr><td align="left">&#8805;55&#160;years</td><td char="." align="char">51.6</td><td align="left">1.4 (0.5&#8211;3.9)</td><td char="." align="char">.6</td></tr><tr><td align="left" colspan="4"><italic>Positive lymph nodes</italic></td></tr><tr><td align="left">&#8804;2</td><td char="." align="char">44.4</td><td align="left">Ref</td><td char="." align="char"/></tr><tr><td align="left">&gt;2</td><td char="." align="char">55.0</td><td align="left">1.5 (0.5&#8211;4.6)</td><td char="." align="char">.5</td></tr><tr><td align="left" colspan="4"><italic>Extranodal growth</italic></td></tr><tr><td align="left">Yes</td><td char="." align="char">52.2</td><td align="left">Ref</td><td char="." align="char"/></tr><tr><td align="left">No</td><td char="." align="char">48.4</td><td align="left">0.9 (0.3&#8211;2.5)</td><td char="." align="char">.8</td></tr><tr><td align="left" colspan="4"><italic>Tumor size</italic></td></tr><tr><td align="left">&lt;3&#160;cm</td><td char="." align="char">35.7</td><td align="left">Ref</td><td char="." align="char"/></tr><tr><td align="left">&#8805;3&#160;cm</td><td char="." align="char">65.4</td><td align="left">3.4 (1.1&#8211;10.4)</td><td char="." align="char">.03</td></tr></tbody></table>
###xml 638 688 632 680 <p xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" textid="29">Elevated S-100B was defined as S-100B&#160;&#8805;&#160;0.15&#160;g/L</p>
###xml 688 691 680 683 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Ref</italic>
###xml 688 710 680 702 <p xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" textid="30"><italic>Ref</italic> reference category</p>
###xml 638 710 632 702 <table-wrap-foot xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="29">Elevated S-100B was defined as S-100B&#160;&#8805;&#160;0.15&#160;g/L</p><p textid="30"><italic>Ref</italic> reference category</p></table-wrap-foot>
###xml 253 710 253 702 <table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab2"><label>Table&#160;2</label><caption><p textid="28">Logistic regression analysis on elevated preoperative S-100B in stage III melanoma patients</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Variable</th><th align="left">Elevated preoperative S-100B (%)</th><th align="left">OR</th><th align="left"><italic>P</italic> value</th></tr></thead><tbody><tr><td align="left" colspan="4"><italic>Sex</italic></td></tr><tr><td align="left">Male</td><td char="." align="char">51.9</td><td align="left">Ref</td><td char="." align="char"/></tr><tr><td align="left">Female</td><td char="." align="char">44.8</td><td align="left">0.8 (0.3&#8211;2.2)</td><td char="." align="char">.6</td></tr><tr><td align="left" colspan="4"><italic>Age</italic></td></tr><tr><td align="left">&lt;55&#160;years</td><td char="." align="char">44.0</td><td align="left">Ref</td><td char="." align="char"/></tr><tr><td align="left">&#8805;55&#160;years</td><td char="." align="char">51.6</td><td align="left">1.4 (0.5&#8211;3.9)</td><td char="." align="char">.6</td></tr><tr><td align="left" colspan="4"><italic>Positive lymph nodes</italic></td></tr><tr><td align="left">&#8804;2</td><td char="." align="char">44.4</td><td align="left">Ref</td><td char="." align="char"/></tr><tr><td align="left">&gt;2</td><td char="." align="char">55.0</td><td align="left">1.5 (0.5&#8211;4.6)</td><td char="." align="char">.5</td></tr><tr><td align="left" colspan="4"><italic>Extranodal growth</italic></td></tr><tr><td align="left">Yes</td><td char="." align="char">52.2</td><td align="left">Ref</td><td char="." align="char"/></tr><tr><td align="left">No</td><td char="." align="char">48.4</td><td align="left">0.9 (0.3&#8211;2.5)</td><td char="." align="char">.8</td></tr><tr><td align="left" colspan="4"><italic>Tumor size</italic></td></tr><tr><td align="left">&lt;3&#160;cm</td><td char="." align="char">35.7</td><td align="left">Ref</td><td char="." align="char"/></tr><tr><td align="left">&#8805;3&#160;cm</td><td char="." align="char">65.4</td><td align="left">3.4 (1.1&#8211;10.4)</td><td char="." align="char">.03</td></tr></tbody></table><table-wrap-foot><p textid="29">Elevated S-100B was defined as S-100B&#160;&#8805;&#160;0.15&#160;g/L</p><p textid="30"><italic>Ref</italic> reference category</p></table-wrap-foot></table-wrap>
Preoperative S-100B elevation was associated with increased lymph node size (odds ratio [OR] 3.4, P = .03), however not significantly with extranodal growth (P = .8), more than 2 positive lymph nodes (P = .5), age (P = .6), or gender (P = .6) (Table 2).Table 2Logistic regression analysis on elevated preoperative S-100B in stage III melanoma patientsVariableElevated preoperative S-100B (%)ORP valueSexMale51.9RefFemale44.80.8 (0.3-2.2).6Age<55 years44.0Ref>/=55 years51.61.4 (0.5-3.9).6Positive lymph nodes</=244.4Ref>255.01.5 (0.5-4.6).5Extranodal growthYes52.2RefNo48.40.9 (0.3-2.5).8Tumor size<3 cm35.7Ref>/=3 cm65.43.4 (1.1-10.4).03Elevated S-100B was defined as S-100B >/= 0.15 g/LRef reference category
###end p 27
###begin p 28
###xml 83 91 <span type="species:ncbi:9606">patients</span>
Logistic regression analysis on elevated preoperative S-100B in stage III melanoma patients
###end p 28
###begin p 29
Elevated S-100B was defined as S-100B >/= 0.15 g/L
###end p 29
###begin p 30
###xml 0 3 0 3 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Ref</italic>
Ref reference category
###end p 30
###begin title 31
###xml 7 8 7 8 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">-</bold>
Disease-Free Survival
###end title 31
###begin p 32
###xml 240 241 240 241 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab3" ref-type="table">3</xref>
###xml 522 523 522 523 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 680 681 680 681 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 694 695 694 695 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 697 704 697 704 <label xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Table&#160;3</label>
###xml 704 767 704 767 <p xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" textid="33">Disease-free survival (DFS) of AJCC stage III melanoma patients</p>
###xml 704 767 704 767 <caption xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="33">Disease-free survival (DFS) of AJCC stage III melanoma patients</p></caption>
###xml 767 775 767 775 <th xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left" rowspan="2">Variable</th>
###xml 775 789 775 789 <th xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left" rowspan="2">2-year DFS (%)</th>
###xml 789 808 789 808 <th xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="2">Univariate analysis</th>
###xml 808 829 808 829 <th xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="2">Multivariate analysis</th>
###xml 767 829 767 829 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left" rowspan="2">Variable</th><th align="left" rowspan="2">2-year DFS (%)</th><th align="left" colspan="2">Univariate analysis</th><th align="left" colspan="2">Multivariate analysis</th></tr>
###xml 829 840 829 840 <th xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">HR (95% CI)</th>
###xml 840 841 840 841 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 840 847 840 847 <th xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><italic>P</italic> value</th>
###xml 847 858 847 858 <th xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">HR (95% CI)</th>
###xml 858 859 858 859 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 858 865 858 865 <th xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><italic>P</italic> value</th>
###xml 829 865 829 865 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left">HR (95% CI)</th><th align="left"><italic>P</italic> value</th><th align="left">HR (95% CI)</th><th align="left"><italic>P</italic> value</th></tr>
###xml 767 865 767 865 <thead xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th align="left" rowspan="2">Variable</th><th align="left" rowspan="2">2-year DFS (%)</th><th align="left" colspan="2">Univariate analysis</th><th align="left" colspan="2">Multivariate analysis</th></tr><tr><th align="left">HR (95% CI)</th><th align="left"><italic>P</italic> value</th><th align="left">HR (95% CI)</th><th align="left"><italic>P</italic> value</th></tr></thead>
###xml 865 868 865 868 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Sex</italic>
###xml 865 868 865 868 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="6"><italic>Sex</italic></td>
###xml 865 868 865 868 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left" colspan="6"><italic>Sex</italic></td></tr>
###xml 868 872 868 872 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Male</td>
###xml 872 874 872 874 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">45</td>
###xml 874 877 874 877 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Ref</td>
###xml 877 877 877 877 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"/>
###xml 877 877 877 877 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 877 877 877 877 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"/>
###xml 868 877 868 877 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Male</td><td char="." align="char">45</td><td align="left">Ref</td><td char="." align="char"/><td align="left"/><td char="." align="char"/></tr>
###xml 877 883 877 883 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Female</td>
###xml 883 885 883 885 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">47</td>
###xml 885 898 885 898 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1.2 (0.5&#8211;2.6)</td>
###xml 898 900 898 900 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">.7</td>
###xml 900 900 900 900 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 900 900 900 900 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"/>
###xml 877 900 877 900 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Female</td><td char="." align="char">47</td><td align="left">1.2 (0.5&#8211;2.6)</td><td char="." align="char">.7</td><td align="left"/><td char="." align="char"/></tr>
###xml 900 923 900 923 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Localization lymph node</italic>
###xml 900 923 900 923 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="6"><italic>Localization lymph node</italic></td>
###xml 900 923 900 923 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left" colspan="6"><italic>Localization lymph node</italic></td></tr>
###xml 923 927 923 927 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Neck</td>
###xml 927 929 927 929 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">83</td>
###xml 929 932 929 932 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Ref</td>
###xml 932 932 932 932 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"/>
###xml 932 932 932 932 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 932 932 932 932 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"/>
###xml 923 932 923 932 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Neck</td><td char="." align="char">83</td><td align="left">Ref</td><td char="." align="char"/><td align="left"/><td char="." align="char"/></tr>
###xml 932 938 932 938 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Axilla</td>
###xml 938 940 938 940 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">51</td>
###xml 940 952 940 952 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">3.3 (0.4&#8211;26)</td>
###xml 952 952 952 952 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"/>
###xml 952 952 952 952 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 952 952 952 952 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"/>
###xml 932 952 932 952 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Axilla</td><td char="." align="char">51</td><td align="left">3.3 (0.4&#8211;26)</td><td char="." align="char"/><td align="left"/><td char="." align="char"/></tr>
###xml 952 957 952 957 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Groin</td>
###xml 957 959 957 959 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">36</td>
###xml 959 971 959 971 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">4.9 (0.7&#8211;37)</td>
###xml 971 973 971 973 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">.2</td>
###xml 973 973 973 973 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 973 973 973 973 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"/>
###xml 952 973 952 973 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Groin</td><td char="." align="char">36</td><td align="left">4.9 (0.7&#8211;37)</td><td char="." align="char">.2</td><td align="left"/><td char="." align="char"/></tr>
###xml 973 993 973 993 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Positive lymph nodes</italic>
###xml 973 993 973 993 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="6"><italic>Positive lymph nodes</italic></td>
###xml 973 993 973 993 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left" colspan="6"><italic>Positive lymph nodes</italic></td></tr>
###xml 993 997 993 995 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8804;2</td>
###xml 997 999 995 997 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">64</td>
###xml 999 1002 997 1000 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Ref</td>
###xml 1002 1002 1000 1000 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"/>
###xml 1002 1005 1000 1003 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Ref</td>
###xml 1005 1005 1003 1003 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"/>
###xml 993 1005 993 1003 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#8804;2</td><td char="." align="char">64</td><td align="left">Ref</td><td char="." align="char"/><td align="left">Ref</td><td char="." align="char"/></tr>
###xml 1005 1007 1003 1005 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&gt;2</td>
###xml 1007 1009 1005 1007 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">23</td>
###xml 1009 1022 1007 1020 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">3.3 (1.5&#8211;7.5)</td>
###xml 1022 1026 1020 1024 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">.004</td>
###xml 1026 1039 1024 1037 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1.6 (0.6&#8211;4.3)</td>
###xml 1039 1041 1037 1039 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">.3</td>
###xml 1005 1041 1003 1039 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&gt;2</td><td char="." align="char">23</td><td align="left">3.3 (1.5&#8211;7.5)</td><td char="." align="char">.004</td><td align="left">1.6 (0.6&#8211;4.3)</td><td char="." align="char">.3</td></tr>
###xml 1041 1058 1039 1056 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Extranodal growth</italic>
###xml 1041 1058 1039 1056 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="6"><italic>Extranodal growth</italic></td>
###xml 1041 1058 1039 1056 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left" colspan="6"><italic>Extranodal growth</italic></td></tr>
###xml 1058 1061 1056 1059 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Yes</td>
###xml 1061 1063 1059 1061 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">28</td>
###xml 1063 1066 1061 1064 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Ref</td>
###xml 1066 1066 1064 1064 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"/>
###xml 1066 1069 1064 1067 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Ref</td>
###xml 1069 1069 1067 1067 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"/>
###xml 1058 1069 1056 1067 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Yes</td><td char="." align="char">28</td><td align="left">Ref</td><td char="." align="char"/><td align="left">Ref</td><td char="." align="char"/></tr>
###xml 1069 1071 1067 1069 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">No</td>
###xml 1071 1073 1069 1071 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">58</td>
###xml 1073 1086 1071 1084 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.4 (0.2&#8211;0.8)</td>
###xml 1086 1089 1084 1087 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">.02</td>
###xml 1089 1102 1087 1100 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.4 (0.1&#8211;1.0)</td>
###xml 1102 1105 1100 1103 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">.05</td>
###xml 1069 1105 1067 1103 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">No</td><td char="." align="char">58</td><td align="left">0.4 (0.2&#8211;0.8)</td><td char="." align="char">.02</td><td align="left">0.4 (0.1&#8211;1.0)</td><td char="." align="char">.05</td></tr>
###xml 1105 1125 1103 1123 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Lymph node size (cm)</italic>
###xml 1105 1125 1103 1123 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="6"><italic>Lymph node size (cm)</italic></td>
###xml 1105 1125 1103 1123 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left" colspan="6"><italic>Lymph node size (cm)</italic></td></tr>
###xml 1125 1127 1123 1125 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&lt;3</td>
###xml 1127 1129 1125 1127 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">53</td>
###xml 1129 1132 1127 1130 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Ref</td>
###xml 1132 1132 1130 1130 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"/>
###xml 1132 1132 1130 1130 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 1132 1132 1130 1130 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"/>
###xml 1125 1132 1123 1130 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&lt;3</td><td char="." align="char">53</td><td align="left">Ref</td><td char="." align="char"/><td align="left"/><td char="." align="char"/></tr>
###xml 1132 1136 1130 1132 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8805;3</td>
###xml 1136 1138 1132 1134 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">35</td>
###xml 1138 1151 1134 1147 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1.5 (0.7&#8211;3.3)</td>
###xml 1151 1153 1147 1149 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">.4</td>
###xml 1153 1153 1149 1149 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 1153 1153 1149 1149 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"/>
###xml 1132 1153 1130 1149 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#8805;3</td><td char="." align="char">35</td><td align="left">1.5 (0.7&#8211;3.3)</td><td char="." align="char">.4</td><td align="left"/><td char="." align="char"/></tr>
###xml 1153 1158 1149 1154 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Stage</italic>
###xml 1153 1158 1149 1154 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="6"><italic>Stage</italic></td>
###xml 1153 1158 1149 1154 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left" colspan="6"><italic>Stage</italic></td></tr>
###xml 1158 1162 1154 1158 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">IIIB</td>
###xml 1162 1164 1158 1160 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">69</td>
###xml 1164 1167 1160 1163 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Ref</td>
###xml 1167 1167 1163 1163 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"/>
###xml 1167 1170 1163 1166 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Ref</td>
###xml 1170 1170 1166 1166 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"/>
###xml 1158 1170 1154 1166 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">IIIB</td><td char="." align="char">69</td><td align="left">Ref</td><td char="." align="char"/><td align="left">Ref</td><td char="." align="char"/></tr>
###xml 1170 1174 1166 1170 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">IIIC</td>
###xml 1174 1176 1170 1172 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">23</td>
###xml 1176 1189 1172 1185 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">3.9 (1.6&#8211;9.5)</td>
###xml 1189 1193 1185 1189 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">.003</td>
###xml 1193 1206 1189 1202 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1.8 (0.6&#8211;5.2)</td>
###xml 1206 1208 1202 1204 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">.3</td>
###xml 1170 1208 1166 1204 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">IIIC</td><td char="." align="char">23</td><td align="left">3.9 (1.6&#8211;9.5)</td><td char="." align="char">.003</td><td align="left">1.8 (0.6&#8211;5.2)</td><td char="." align="char">.3</td></tr>
###xml 1208 1227 1204 1223 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Preoperative S-100B</italic>
###xml 1208 1227 1204 1223 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="6"><italic>Preoperative S-100B</italic></td>
###xml 1208 1227 1204 1223 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left" colspan="6"><italic>Preoperative S-100B</italic></td></tr>
###xml 1227 1233 1223 1229 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Normal</td>
###xml 1233 1235 1229 1231 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">61</td>
###xml 1235 1238 1231 1234 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Ref</td>
###xml 1238 1238 1234 1234 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"/>
###xml 1238 1241 1234 1237 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Ref</td>
###xml 1241 1241 1237 1237 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"/>
###xml 1227 1241 1223 1237 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Normal</td><td char="." align="char">61</td><td align="left">Ref</td><td char="." align="char"/><td align="left">Ref</td><td char="." align="char"/></tr>
###xml 1241 1249 1237 1245 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Elevated</td>
###xml 1249 1251 1245 1247 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">34</td>
###xml 1251 1264 1247 1260 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">2.6 (1.1&#8211;6.0)</td>
###xml 1264 1267 1260 1263 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">.03</td>
###xml 1267 1280 1263 1276 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">2.6 (1.1&#8211;6.1)</td>
###xml 1280 1283 1276 1279 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">.03</td>
###xml 1241 1283 1237 1279 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Elevated</td><td char="." align="char">34</td><td align="left">2.6 (1.1&#8211;6.0)</td><td char="." align="char">.03</td><td align="left">2.6 (1.1&#8211;6.1)</td><td char="." align="char">.03</td></tr>
###xml 1283 1303 1279 1299 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Postoperative S-100B</italic>
###xml 1283 1303 1279 1299 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="6"><italic>Postoperative S-100B</italic></td>
###xml 1283 1303 1279 1299 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left" colspan="6"><italic>Postoperative S-100B</italic></td></tr>
###xml 1303 1314 1299 1310 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">No increase</td>
###xml 1314 1316 1310 1312 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">51</td>
###xml 1316 1319 1312 1315 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Ref</td>
###xml 1319 1319 1315 1315 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"/>
###xml 1319 1322 1315 1318 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Ref</td>
###xml 1322 1322 1318 1318 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"/>
###xml 1303 1322 1299 1318 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">No increase</td><td char="." align="char">51</td><td align="left">Ref</td><td char="." align="char"/><td align="left">Ref</td><td char="." align="char"/></tr>
###xml 1322 1330 1318 1326 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Increase</td>
###xml 1330 1332 1326 1328 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">30</td>
###xml 1332 1345 1328 1341 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">2.0 (0.8&#8211;4.8)</td>
###xml 1345 1347 1341 1343 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">.1</td>
###xml 1347 1360 1343 1356 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">2.6 (0.9&#8211;7.2)</td>
###xml 1360 1363 1356 1359 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">.07</td>
###xml 1322 1363 1318 1359 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Increase</td><td char="." align="char">30</td><td align="left">2.0 (0.8&#8211;4.8)</td><td char="." align="char">.1</td><td align="left">2.6 (0.9&#8211;7.2)</td><td char="." align="char">.07</td></tr>
###xml 865 1363 865 1359 <tbody xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td align="left" colspan="6"><italic>Sex</italic></td></tr><tr><td align="left">Male</td><td char="." align="char">45</td><td align="left">Ref</td><td char="." align="char"/><td align="left"/><td char="." align="char"/></tr><tr><td align="left">Female</td><td char="." align="char">47</td><td align="left">1.2 (0.5&#8211;2.6)</td><td char="." align="char">.7</td><td align="left"/><td char="." align="char"/></tr><tr><td align="left" colspan="6"><italic>Localization lymph node</italic></td></tr><tr><td align="left">Neck</td><td char="." align="char">83</td><td align="left">Ref</td><td char="." align="char"/><td align="left"/><td char="." align="char"/></tr><tr><td align="left">Axilla</td><td char="." align="char">51</td><td align="left">3.3 (0.4&#8211;26)</td><td char="." align="char"/><td align="left"/><td char="." align="char"/></tr><tr><td align="left">Groin</td><td char="." align="char">36</td><td align="left">4.9 (0.7&#8211;37)</td><td char="." align="char">.2</td><td align="left"/><td char="." align="char"/></tr><tr><td align="left" colspan="6"><italic>Positive lymph nodes</italic></td></tr><tr><td align="left">&#8804;2</td><td char="." align="char">64</td><td align="left">Ref</td><td char="." align="char"/><td align="left">Ref</td><td char="." align="char"/></tr><tr><td align="left">&gt;2</td><td char="." align="char">23</td><td align="left">3.3 (1.5&#8211;7.5)</td><td char="." align="char">.004</td><td align="left">1.6 (0.6&#8211;4.3)</td><td char="." align="char">.3</td></tr><tr><td align="left" colspan="6"><italic>Extranodal growth</italic></td></tr><tr><td align="left">Yes</td><td char="." align="char">28</td><td align="left">Ref</td><td char="." align="char"/><td align="left">Ref</td><td char="." align="char"/></tr><tr><td align="left">No</td><td char="." align="char">58</td><td align="left">0.4 (0.2&#8211;0.8)</td><td char="." align="char">.02</td><td align="left">0.4 (0.1&#8211;1.0)</td><td char="." align="char">.05</td></tr><tr><td align="left" colspan="6"><italic>Lymph node size (cm)</italic></td></tr><tr><td align="left">&lt;3</td><td char="." align="char">53</td><td align="left">Ref</td><td char="." align="char"/><td align="left"/><td char="." align="char"/></tr><tr><td align="left">&#8805;3</td><td char="." align="char">35</td><td align="left">1.5 (0.7&#8211;3.3)</td><td char="." align="char">.4</td><td align="left"/><td char="." align="char"/></tr><tr><td align="left" colspan="6"><italic>Stage</italic></td></tr><tr><td align="left">IIIB</td><td char="." align="char">69</td><td align="left">Ref</td><td char="." align="char"/><td align="left">Ref</td><td char="." align="char"/></tr><tr><td align="left">IIIC</td><td char="." align="char">23</td><td align="left">3.9 (1.6&#8211;9.5)</td><td char="." align="char">.003</td><td align="left">1.8 (0.6&#8211;5.2)</td><td char="." align="char">.3</td></tr><tr><td align="left" colspan="6"><italic>Preoperative S-100B</italic></td></tr><tr><td align="left">Normal</td><td char="." align="char">61</td><td align="left">Ref</td><td char="." align="char"/><td align="left">Ref</td><td char="." align="char"/></tr><tr><td align="left">Elevated</td><td char="." align="char">34</td><td align="left">2.6 (1.1&#8211;6.0)</td><td char="." align="char">.03</td><td align="left">2.6 (1.1&#8211;6.1)</td><td char="." align="char">.03</td></tr><tr><td align="left" colspan="6"><italic>Postoperative S-100B</italic></td></tr><tr><td align="left">No increase</td><td char="." align="char">51</td><td align="left">Ref</td><td char="." align="char"/><td align="left">Ref</td><td char="." align="char"/></tr><tr><td align="left">Increase</td><td char="." align="char">30</td><td align="left">2.0 (0.8&#8211;4.8)</td><td char="." align="char">.1</td><td align="left">2.6 (0.9&#8211;7.2)</td><td char="." align="char">.07</td></tr></tbody>
###xml 767 1363 767 1359 <table xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">Variable</th><th align="left" rowspan="2">2-year DFS (%)</th><th align="left" colspan="2">Univariate analysis</th><th align="left" colspan="2">Multivariate analysis</th></tr><tr><th align="left">HR (95% CI)</th><th align="left"><italic>P</italic> value</th><th align="left">HR (95% CI)</th><th align="left"><italic>P</italic> value</th></tr></thead><tbody><tr><td align="left" colspan="6"><italic>Sex</italic></td></tr><tr><td align="left">Male</td><td char="." align="char">45</td><td align="left">Ref</td><td char="." align="char"/><td align="left"/><td char="." align="char"/></tr><tr><td align="left">Female</td><td char="." align="char">47</td><td align="left">1.2 (0.5&#8211;2.6)</td><td char="." align="char">.7</td><td align="left"/><td char="." align="char"/></tr><tr><td align="left" colspan="6"><italic>Localization lymph node</italic></td></tr><tr><td align="left">Neck</td><td char="." align="char">83</td><td align="left">Ref</td><td char="." align="char"/><td align="left"/><td char="." align="char"/></tr><tr><td align="left">Axilla</td><td char="." align="char">51</td><td align="left">3.3 (0.4&#8211;26)</td><td char="." align="char"/><td align="left"/><td char="." align="char"/></tr><tr><td align="left">Groin</td><td char="." align="char">36</td><td align="left">4.9 (0.7&#8211;37)</td><td char="." align="char">.2</td><td align="left"/><td char="." align="char"/></tr><tr><td align="left" colspan="6"><italic>Positive lymph nodes</italic></td></tr><tr><td align="left">&#8804;2</td><td char="." align="char">64</td><td align="left">Ref</td><td char="." align="char"/><td align="left">Ref</td><td char="." align="char"/></tr><tr><td align="left">&gt;2</td><td char="." align="char">23</td><td align="left">3.3 (1.5&#8211;7.5)</td><td char="." align="char">.004</td><td align="left">1.6 (0.6&#8211;4.3)</td><td char="." align="char">.3</td></tr><tr><td align="left" colspan="6"><italic>Extranodal growth</italic></td></tr><tr><td align="left">Yes</td><td char="." align="char">28</td><td align="left">Ref</td><td char="." align="char"/><td align="left">Ref</td><td char="." align="char"/></tr><tr><td align="left">No</td><td char="." align="char">58</td><td align="left">0.4 (0.2&#8211;0.8)</td><td char="." align="char">.02</td><td align="left">0.4 (0.1&#8211;1.0)</td><td char="." align="char">.05</td></tr><tr><td align="left" colspan="6"><italic>Lymph node size (cm)</italic></td></tr><tr><td align="left">&lt;3</td><td char="." align="char">53</td><td align="left">Ref</td><td char="." align="char"/><td align="left"/><td char="." align="char"/></tr><tr><td align="left">&#8805;3</td><td char="." align="char">35</td><td align="left">1.5 (0.7&#8211;3.3)</td><td char="." align="char">.4</td><td align="left"/><td char="." align="char"/></tr><tr><td align="left" colspan="6"><italic>Stage</italic></td></tr><tr><td align="left">IIIB</td><td char="." align="char">69</td><td align="left">Ref</td><td char="." align="char"/><td align="left">Ref</td><td char="." align="char"/></tr><tr><td align="left">IIIC</td><td char="." align="char">23</td><td align="left">3.9 (1.6&#8211;9.5)</td><td char="." align="char">.003</td><td align="left">1.8 (0.6&#8211;5.2)</td><td char="." align="char">.3</td></tr><tr><td align="left" colspan="6"><italic>Preoperative S-100B</italic></td></tr><tr><td align="left">Normal</td><td char="." align="char">61</td><td align="left">Ref</td><td char="." align="char"/><td align="left">Ref</td><td char="." align="char"/></tr><tr><td align="left">Elevated</td><td char="." align="char">34</td><td align="left">2.6 (1.1&#8211;6.0)</td><td char="." align="char">.03</td><td align="left">2.6 (1.1&#8211;6.1)</td><td char="." align="char">.03</td></tr><tr><td align="left" colspan="6"><italic>Postoperative S-100B</italic></td></tr><tr><td align="left">No increase</td><td char="." align="char">51</td><td align="left">Ref</td><td char="." align="char"/><td align="left">Ref</td><td char="." align="char"/></tr><tr><td align="left">Increase</td><td char="." align="char">30</td><td align="left">2.0 (0.8&#8211;4.8)</td><td char="." align="char">.1</td><td align="left">2.6 (0.9&#8211;7.2)</td><td char="." align="char">.07</td></tr></tbody></table>
###xml 1363 1366 1359 1362 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Ref</italic>
###xml 1363 1385 1359 1381 <p xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" textid="34"><italic>Ref</italic> reference category</p>
###xml 1363 1385 1359 1381 <table-wrap-foot xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="34"><italic>Ref</italic> reference category</p></table-wrap-foot>
###xml 697 1385 697 1381 <table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab3"><label>Table&#160;3</label><caption><p textid="33">Disease-free survival (DFS) of AJCC stage III melanoma patients</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">Variable</th><th align="left" rowspan="2">2-year DFS (%)</th><th align="left" colspan="2">Univariate analysis</th><th align="left" colspan="2">Multivariate analysis</th></tr><tr><th align="left">HR (95% CI)</th><th align="left"><italic>P</italic> value</th><th align="left">HR (95% CI)</th><th align="left"><italic>P</italic> value</th></tr></thead><tbody><tr><td align="left" colspan="6"><italic>Sex</italic></td></tr><tr><td align="left">Male</td><td char="." align="char">45</td><td align="left">Ref</td><td char="." align="char"/><td align="left"/><td char="." align="char"/></tr><tr><td align="left">Female</td><td char="." align="char">47</td><td align="left">1.2 (0.5&#8211;2.6)</td><td char="." align="char">.7</td><td align="left"/><td char="." align="char"/></tr><tr><td align="left" colspan="6"><italic>Localization lymph node</italic></td></tr><tr><td align="left">Neck</td><td char="." align="char">83</td><td align="left">Ref</td><td char="." align="char"/><td align="left"/><td char="." align="char"/></tr><tr><td align="left">Axilla</td><td char="." align="char">51</td><td align="left">3.3 (0.4&#8211;26)</td><td char="." align="char"/><td align="left"/><td char="." align="char"/></tr><tr><td align="left">Groin</td><td char="." align="char">36</td><td align="left">4.9 (0.7&#8211;37)</td><td char="." align="char">.2</td><td align="left"/><td char="." align="char"/></tr><tr><td align="left" colspan="6"><italic>Positive lymph nodes</italic></td></tr><tr><td align="left">&#8804;2</td><td char="." align="char">64</td><td align="left">Ref</td><td char="." align="char"/><td align="left">Ref</td><td char="." align="char"/></tr><tr><td align="left">&gt;2</td><td char="." align="char">23</td><td align="left">3.3 (1.5&#8211;7.5)</td><td char="." align="char">.004</td><td align="left">1.6 (0.6&#8211;4.3)</td><td char="." align="char">.3</td></tr><tr><td align="left" colspan="6"><italic>Extranodal growth</italic></td></tr><tr><td align="left">Yes</td><td char="." align="char">28</td><td align="left">Ref</td><td char="." align="char"/><td align="left">Ref</td><td char="." align="char"/></tr><tr><td align="left">No</td><td char="." align="char">58</td><td align="left">0.4 (0.2&#8211;0.8)</td><td char="." align="char">.02</td><td align="left">0.4 (0.1&#8211;1.0)</td><td char="." align="char">.05</td></tr><tr><td align="left" colspan="6"><italic>Lymph node size (cm)</italic></td></tr><tr><td align="left">&lt;3</td><td char="." align="char">53</td><td align="left">Ref</td><td char="." align="char"/><td align="left"/><td char="." align="char"/></tr><tr><td align="left">&#8805;3</td><td char="." align="char">35</td><td align="left">1.5 (0.7&#8211;3.3)</td><td char="." align="char">.4</td><td align="left"/><td char="." align="char"/></tr><tr><td align="left" colspan="6"><italic>Stage</italic></td></tr><tr><td align="left">IIIB</td><td char="." align="char">69</td><td align="left">Ref</td><td char="." align="char"/><td align="left">Ref</td><td char="." align="char"/></tr><tr><td align="left">IIIC</td><td char="." align="char">23</td><td align="left">3.9 (1.6&#8211;9.5)</td><td char="." align="char">.003</td><td align="left">1.8 (0.6&#8211;5.2)</td><td char="." align="char">.3</td></tr><tr><td align="left" colspan="6"><italic>Preoperative S-100B</italic></td></tr><tr><td align="left">Normal</td><td char="." align="char">61</td><td align="left">Ref</td><td char="." align="char"/><td align="left">Ref</td><td char="." align="char"/></tr><tr><td align="left">Elevated</td><td char="." align="char">34</td><td align="left">2.6 (1.1&#8211;6.0)</td><td char="." align="char">.03</td><td align="left">2.6 (1.1&#8211;6.1)</td><td char="." align="char">.03</td></tr><tr><td align="left" colspan="6"><italic>Postoperative S-100B</italic></td></tr><tr><td align="left">No increase</td><td char="." align="char">51</td><td align="left">Ref</td><td char="." align="char"/><td align="left">Ref</td><td char="." align="char"/></tr><tr><td align="left">Increase</td><td char="." align="char">30</td><td align="left">2.0 (0.8&#8211;4.8)</td><td char="." align="char">.1</td><td align="left">2.6 (0.9&#8211;7.2)</td><td char="." align="char">.07</td></tr></tbody></table><table-wrap-foot><p textid="34"><italic>Ref</italic> reference category</p></table-wrap-foot></table-wrap>
###xml 1385 1391 1381 1387 <label xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;1</label>
###xml 1497 1498 1493 1494 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 1644 1645 1640 1641 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1654 1655 1650 1651 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 1752 1753 1748 1749 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1391 1759 1387 1755 <p xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" textid="35">Kaplan-Meier curve for preoperative S-100B and disease-free survival of AJCC stage III melanoma patients. <bold>a</bold> Elevated preoperative S-100B (34% 2-year DFS) versus not elevated (61% 2-year DFS) levels are associated with a decreased disease-free survival (<italic>P</italic>&#160;=&#160;.03). <bold>b</bold> Increasing postoperative S-100B levels (30% 2-year DFS) versus not increasing (51% 2-year DFS) (<italic>P</italic>&#160;=&#160;.1)</p>
###xml 1391 1759 1387 1755 <caption xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="35">Kaplan-Meier curve for preoperative S-100B and disease-free survival of AJCC stage III melanoma patients. <bold>a</bold> Elevated preoperative S-100B (34% 2-year DFS) versus not elevated (61% 2-year DFS) levels are associated with a decreased disease-free survival (<italic>P</italic>&#160;=&#160;.03). <bold>b</bold> Increasing postoperative S-100B levels (30% 2-year DFS) versus not increasing (51% 2-year DFS) (<italic>P</italic>&#160;=&#160;.1)</p></caption>
###xml 1759 1759 1755 1755 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="10434_2009_629_Fig1_HTML" id="MO1"/>
###xml 1385 1759 1381 1755 <fig xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig1"><label>Fig.&#160;1</label><caption><p textid="35">Kaplan-Meier curve for preoperative S-100B and disease-free survival of AJCC stage III melanoma patients. <bold>a</bold> Elevated preoperative S-100B (34% 2-year DFS) versus not elevated (61% 2-year DFS) levels are associated with a decreased disease-free survival (<italic>P</italic>&#160;=&#160;.03). <bold>b</bold> Increasing postoperative S-100B levels (30% 2-year DFS) versus not increasing (51% 2-year DFS) (<italic>P</italic>&#160;=&#160;.1)</p></caption><graphic xlink:href="10434_2009_629_Fig1_HTML" id="MO1"/></fig>
###xml 103 111 <span type="species:ncbi:9606">patients</span>
###xml 131 139 <span type="species:ncbi:9606">patients</span>
###xml 185 193 <span type="species:ncbi:9606">patients</span>
###xml 356 364 <span type="species:ncbi:9606">patients</span>
###xml 437 445 <span type="species:ncbi:9606">patients</span>
###xml 539 547 <span type="species:ncbi:9606">patients</span>
###xml 622 630 <span type="species:ncbi:9606">patients</span>
###xml 1487 1495 <span type="species:ncbi:9606">patients</span>
During a median follow-up of 14.2 months (range 0.6-40.9) months, tumor recurrence was diagnosed in 24 patients (43%), of which 17 patients were diagnosed with distant metastasis and 7 patients with a regional recurrence. As shown in Table 3, DFS was not associated with sex, localization of the lymph node, or the size of the lymph nodes. Two-year DFS in patients with elevated preoperative S-100B concentrations was 34% versus 61% for patients without elevated preoperative S-100B concentrations (hazard ratio [HR] 2.6, P = .03). In the patients whose S-100B increased postoperatively, 2-year DFS was 30% versus 51% for patients without a postoperative S-100B increase (HR 2.0, P = .1) (Fig. 1).Table 3Disease-free survival (DFS) of AJCC stage III melanoma patientsVariable2-year DFS (%)Univariate analysisMultivariate analysisHR (95% CI)P valueHR (95% CI)P valueSexMale45RefFemale471.2 (0.5-2.6).7Localization lymph nodeNeck83RefAxilla513.3 (0.4-26)Groin364.9 (0.7-37).2Positive lymph nodes</=264RefRef>2233.3 (1.5-7.5).0041.6 (0.6-4.3).3Extranodal growthYes28RefRefNo580.4 (0.2-0.8).020.4 (0.1-1.0).05Lymph node size (cm)<353Ref>/=3351.5 (0.7-3.3).4StageIIIB69RefRefIIIC233.9 (1.6-9.5).0031.8 (0.6-5.2).3Preoperative S-100BNormal61RefRefElevated342.6 (1.1-6.0).032.6 (1.1-6.1).03Postoperative S-100BNo increase51RefRefIncrease302.0 (0.8-4.8).12.6 (0.9-7.2).07Ref reference categoryFig. 1Kaplan-Meier curve for preoperative S-100B and disease-free survival of AJCC stage III melanoma patients. a Elevated preoperative S-100B (34% 2-year DFS) versus not elevated (61% 2-year DFS) levels are associated with a decreased disease-free survival (P = .03). b Increasing postoperative S-100B levels (30% 2-year DFS) versus not increasing (51% 2-year DFS) (P = .1)
###end p 32
###begin p 33
###xml 55 63 <span type="species:ncbi:9606">patients</span>
Disease-free survival (DFS) of AJCC stage III melanoma patients
###end p 33
###begin p 34
###xml 0 3 0 3 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Ref</italic>
Ref reference category
###end p 34
###begin p 35
###xml 106 107 106 107 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 253 254 253 254 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 263 264 263 264 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 361 362 361 362 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 96 104 <span type="species:ncbi:9606">patients</span>
Kaplan-Meier curve for preoperative S-100B and disease-free survival of AJCC stage III melanoma patients. a Elevated preoperative S-100B (34% 2-year DFS) versus not elevated (61% 2-year DFS) levels are associated with a decreased disease-free survival (P = .03). b Increasing postoperative S-100B levels (30% 2-year DFS) versus not increasing (51% 2-year DFS) (P = .1)
###end p 35
###begin p 36
###xml 171 172 171 172 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 238 239 238 239 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 435 436 435 436 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 297 305 <span type="species:ncbi:9606">Patients</span>
In multivariate analysis (model with positive lymph nodes, extranodal growth, preoperative and postoperative S-100B and substage IIIb or IIIc), extranodal growth (HR 0.4, P = .05), and elevated preoperative S-100B concentrations (HR 2.6, P = .03) were significantly associated with decreased DFS. Patients with increasing postoperative S-100B serum levels showed a trend toward statistical significance when correlated to DFS (HR 2.6, P = .07).
###end p 36
###begin title 37
Discussion
###end title 37
###begin p 38
###xml 397 398 397 398 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab4" ref-type="table">4</xref>
###xml 496 498 496 498 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR20">20</xref>
###xml 499 501 499 501 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR21">21</xref>
###xml 594 601 594 601 <label xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Table&#160;4</label>
###xml 601 673 601 673 <p xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" textid="39">Review literature S-100B values above cut-off point in melanoma patients</p>
###xml 601 673 601 673 <caption xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="39">Review literature S-100B values above cut-off point in melanoma patients</p></caption>
###xml 673 682 673 682 <th xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Reference</th>
###xml 682 685 682 685 <th xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">No.</th>
###xml 685 690 685 690 <th xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Assay</th>
###xml 690 703 690 703 <th xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Cut-off value</th>
###xml 703 713 703 713 <th xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Stage I/II</th>
###xml 713 722 713 722 <th xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Stage III</th>
###xml 722 730 722 730 <th xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Stage IV</th>
###xml 673 730 673 730 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left">Reference</th><th align="left">No.</th><th align="left">Assay</th><th align="left">Cut-off value</th><th align="left">Stage I/II</th><th align="left">Stage III</th><th align="left">Stage IV</th></tr>
###xml 673 730 673 730 <thead xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th align="left">Reference</th><th align="left">No.</th><th align="left">Assay</th><th align="left">Cut-off value</th><th align="left">Stage I/II</th><th align="left">Stage III</th><th align="left">Stage IV</th></tr></thead>
###xml 740 742 740 742 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR14">14</xref>
###xml 730 742 730 742 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Guo et al.<xref ref-type="bibr" rid="CR14">14</xref></td>
###xml 742 745 742 745 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">126</td>
###xml 745 749 745 749 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">IRMA</td>
###xml 749 753 749 753 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.15</td>
###xml 753 755 753 755 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1%</td>
###xml 755 757 755 757 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">9%</td>
###xml 757 760 757 760 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">74%</td>
###xml 730 760 730 760 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Guo et al.<xref ref-type="bibr" rid="CR14">14</xref></td><td char="." align="char">126</td><td align="left">IRMA</td><td align="left">0.15</td><td align="left">1%</td><td align="left">9%</td><td align="left">74%</td></tr>
###xml 775 777 775 777 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR38">38</xref>
###xml 760 777 760 777 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Miliotes et al.<xref ref-type="bibr" rid="CR38">38</xref></td>
###xml 777 779 777 779 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">67</td>
###xml 779 783 779 783 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">IRMA</td>
###xml 783 787 783 787 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.05</td>
###xml 787 792 787 792 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">47.8%</td>
###xml 792 793 792 793 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8211;</td>
###xml 793 794 793 794 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8211;</td>
###xml 760 794 760 794 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Miliotes et al.<xref ref-type="bibr" rid="CR38">38</xref></td><td char="." align="char">67</td><td align="left">IRMA</td><td align="left">0.05</td><td align="left">47.8%</td><td align="left">&#8211;</td><td align="left">&#8211;</td></tr>
###xml 807 809 807 809 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR39">39</xref>
###xml 794 809 794 809 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Abraha et al.<xref ref-type="bibr" rid="CR39">39</xref></td>
###xml 809 811 809 811 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">97</td>
###xml 811 815 811 815 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">IRMA</td>
###xml 815 818 815 818 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.2</td>
###xml 818 820 818 820 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">9%</td>
###xml 820 823 820 823 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">82%</td>
###xml 823 824 823 824 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8211;</td>
###xml 794 824 794 824 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Abraha et al.<xref ref-type="bibr" rid="CR39">39</xref></td><td char="." align="char">97</td><td align="left">IRMA</td><td align="left">0.2</td><td align="left">9%</td><td align="left">82%</td><td align="left">&#8211;</td></tr>
###xml 841 843 841 843 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR40">40</xref>
###xml 824 843 824 843 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Bosserhoff et al.<xref ref-type="bibr" rid="CR40">40</xref></td>
###xml 843 846 843 846 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">112</td>
###xml 846 850 846 850 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">IRMA</td>
###xml 850 854 850 854 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.15</td>
###xml 854 856 854 856 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0%</td>
###xml 856 859 856 859 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">62%</td>
###xml 859 860 859 860 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8211;</td>
###xml 824 860 824 860 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Bosserhoff et al.<xref ref-type="bibr" rid="CR40">40</xref></td><td char="." align="char">112</td><td align="left">IRMA</td><td align="left">0.15</td><td align="left">0%</td><td align="left">62%</td><td align="left">&#8211;</td></tr>
###xml 871 873 871 873 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR24">24</xref>
###xml 860 873 860 873 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Buer et al.<xref ref-type="bibr" rid="CR24">24</xref></td>
###xml 873 875 873 875 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">99</td>
###xml 875 879 875 879 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">IRMA</td>
###xml 879 883 879 883 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">3.00</td>
###xml 883 884 883 884 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8211;</td>
###xml 884 885 884 885 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8211;</td>
###xml 885 890 885 890 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">22.2%</td>
###xml 860 890 860 890 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Buer et al.<xref ref-type="bibr" rid="CR24">24</xref></td><td char="." align="char">99</td><td align="left">IRMA</td><td align="left">3.00</td><td align="left">&#8211;</td><td align="left">&#8211;</td><td align="left">22.2%</td></tr>
###xml 902 904 902 904 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR29">29</xref>
###xml 890 904 890 904 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Henze et al.<xref ref-type="bibr" rid="CR29">29</xref></td>
###xml 904 906 904 906 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">73</td>
###xml 906 910 906 910 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">IRMA</td>
###xml 910 913 910 913 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.3</td>
###xml 913 915 913 915 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">4%</td>
###xml 915 918 915 918 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">21%</td>
###xml 918 921 918 921 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">79%</td>
###xml 890 921 890 921 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Henze et al.<xref ref-type="bibr" rid="CR29">29</xref></td><td char="." align="char">73</td><td align="left">IRMA</td><td align="left">0.3</td><td align="left">4%</td><td align="left">21%</td><td align="left">79%</td></tr>
###xml 934 936 934 936 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR41">41</xref>
###xml 921 936 921 936 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Tofani et al.<xref ref-type="bibr" rid="CR41">41</xref></td>
###xml 936 938 936 938 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">53</td>
###xml 938 942 938 942 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">IRMA</td>
###xml 942 945 942 945 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.5</td>
###xml 945 947 945 947 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0%</td>
###xml 947 950 947 950 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">55%</td>
###xml 950 951 950 951 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8211;</td>
###xml 921 951 921 951 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Tofani et al.<xref ref-type="bibr" rid="CR41">41</xref></td><td char="." align="char">53</td><td align="left">IRMA</td><td align="left">0.5</td><td align="left">0%</td><td align="left">55%</td><td align="left">&#8211;</td></tr>
###xml 965 967 965 967 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR42">42</xref>
###xml 951 967 951 967 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Schultz et al.<xref ref-type="bibr" rid="CR42">42</xref></td>
###xml 967 969 967 969 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">84</td>
###xml 969 973 969 973 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">IRMA</td>
###xml 973 976 973 976 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.3</td>
###xml 976 978 976 978 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0%</td>
###xml 978 981 978 981 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">31%</td>
###xml 981 984 981 984 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">69%</td>
###xml 951 984 951 984 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Schultz et al.<xref ref-type="bibr" rid="CR42">42</xref></td><td char="." align="char">84</td><td align="left">IRMA</td><td align="left">0.3</td><td align="left">0%</td><td align="left">31%</td><td align="left">69%</td></tr>
###xml 998 1000 998 1000 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR43">43</xref>
###xml 984 1000 984 1000 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Bonfrer et al.<xref ref-type="bibr" rid="CR43">43</xref></td>
###xml 1000 1003 1000 1003 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">251</td>
###xml 1003 1006 1003 1006 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">LIA</td>
###xml 1006 1010 1006 1010 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.16</td>
###xml 1010 1018 1010 1018 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">I/II: 1%</td>
###xml 1018 1019 1018 1019 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8211;</td>
###xml 1019 1030 1019 1030 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">III/IV: 79%</td>
###xml 984 1030 984 1030 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Bonfrer et al.<xref ref-type="bibr" rid="CR43">43</xref></td><td char="." align="char">251</td><td align="left">LIA</td><td align="left">0.16</td><td align="left">I/II: 1%</td><td align="left">&#8211;</td><td align="left">III/IV: 79%</td></tr>
###xml 1044 1046 1044 1046 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR44">44</xref>
###xml 1030 1046 1030 1046 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Seregni et al.<xref ref-type="bibr" rid="CR44">44</xref></td>
###xml 1046 1049 1046 1049 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">438</td>
###xml 1049 1053 1049 1053 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">IRMA</td>
###xml 1053 1056 1053 1056 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.2</td>
###xml 1056 1073 1056 1073 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">I: 4.2%, II: 5.3%</td>
###xml 1073 1078 1073 1078 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">38.5%</td>
###xml 1078 1079 1078 1079 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8211;</td>
###xml 1030 1079 1030 1079 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Seregni et al.<xref ref-type="bibr" rid="CR44">44</xref></td><td char="." align="char">438</td><td align="left">IRMA</td><td align="left">0.2</td><td align="left">I: 4.2%, II: 5.3%</td><td align="left">38.5%</td><td align="left">&#8211;</td></tr>
###xml 1095 1097 1095 1097 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR45">45</xref>
###xml 1079 1097 1079 1097 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Hauschild et al.<xref ref-type="bibr" rid="CR45">45</xref></td>
###xml 1097 1100 1097 1100 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">412</td>
###xml 1100 1104 1100 1104 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">IRMA</td>
###xml 1104 1107 1104 1107 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.2</td>
###xml 1107 1109 1107 1109 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">2%</td>
###xml 1109 1112 1109 1112 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">19%</td>
###xml 1112 1115 1112 1115 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">68%</td>
###xml 1079 1115 1079 1115 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Hauschild et al.<xref ref-type="bibr" rid="CR45">45</xref></td><td char="." align="char">412</td><td align="left">IRMA</td><td align="left">0.2</td><td align="left">2%</td><td align="left">19%</td><td align="left">68%</td></tr>
###xml 1127 1129 1127 1129 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR22">22</xref>
###xml 1115 1129 1115 1129 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Curry et al.<xref ref-type="bibr" rid="CR22">22</xref></td>
###xml 1129 1132 1129 1132 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">147</td>
###xml 1132 1140 1132 1140 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">IRMA/LIA</td>
###xml 1140 1148 1140 1148 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.2/0.12</td>
###xml 1148 1149 1148 1149 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8211;</td>
###xml 1149 1158 1149 1158 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">23%/47.5%</td>
###xml 1158 1159 1158 1159 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8211;</td>
###xml 1115 1159 1115 1159 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Curry et al.<xref ref-type="bibr" rid="CR22">22</xref></td><td char="." align="char">147</td><td align="left">IRMA/LIA</td><td align="left">0.2/0.12</td><td align="left">&#8211;</td><td align="left">23%/47.5%</td><td align="left">&#8211;</td></tr>
###xml 1173 1175 1173 1175 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR46">46</xref>
###xml 1159 1175 1159 1175 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Berking et al.<xref ref-type="bibr" rid="CR46">46</xref></td>
###xml 1175 1178 1175 1178 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">352</td>
###xml 1178 1181 1178 1181 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">LIA</td>
###xml 1181 1184 1181 1184 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.2</td>
###xml 1184 1186 1184 1186 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">7%</td>
###xml 1186 1188 1186 1188 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">8%</td>
###xml 1188 1191 1188 1191 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">48%</td>
###xml 1159 1191 1159 1191 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Berking et al.<xref ref-type="bibr" rid="CR46">46</xref></td><td char="." align="char">352</td><td align="left">LIA</td><td align="left">0.2</td><td align="left">7%</td><td align="left">8%</td><td align="left">48%</td></tr>
###xml 1204 1206 1204 1206 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR16">16</xref>
###xml 1191 1206 1191 1206 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Jackel et al.<xref ref-type="bibr" rid="CR16">16</xref></td>
###xml 1206 1209 1206 1209 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">276</td>
###xml 1209 1212 1209 1212 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">LIA</td>
###xml 1212 1216 1212 1216 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.12</td>
###xml 1216 1218 1216 1218 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">6%</td>
###xml 1218 1220 1218 1220 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">5%</td>
###xml 1220 1223 1220 1223 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">48%</td>
###xml 1191 1223 1191 1223 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Jackel et al.<xref ref-type="bibr" rid="CR16">16</xref></td><td char="." align="char">276</td><td align="left">LIA</td><td align="left">0.12</td><td align="left">6%</td><td align="left">5%</td><td align="left">48%</td></tr>
###xml 1236 1238 1236 1238 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR47">47</xref>
###xml 1223 1238 1223 1238 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Kaskel et al.<xref ref-type="bibr" rid="CR47">47</xref></td>
###xml 1238 1241 1238 1241 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">570</td>
###xml 1241 1244 1241 1244 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">LIA</td>
###xml 1244 1248 1244 1248 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.11</td>
###xml 1248 1250 1248 1250 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">9%</td>
###xml 1250 1253 1250 1253 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">94%</td>
###xml 1253 1254 1253 1254 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8211;</td>
###xml 1223 1254 1223 1254 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Kaskel et al.<xref ref-type="bibr" rid="CR47">47</xref></td><td char="." align="char">570</td><td align="left">LIA</td><td align="left">0.11</td><td align="left">9%</td><td align="left">94%</td><td align="left">&#8211;</td></tr>
###xml 1268 1270 1268 1270 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR48">48</xref>
###xml 1254 1270 1254 1270 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Brouard et al.<xref ref-type="bibr" rid="CR48">48</xref></td>
###xml 1270 1273 1270 1273 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">122</td>
###xml 1273 1276 1273 1276 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">LIA</td>
###xml 1276 1280 1276 1280 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.09</td>
###xml 1280 1282 1280 1282 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0%</td>
###xml 1282 1285 1282 1285 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">54%</td>
###xml 1285 1288 1285 1288 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">84%</td>
###xml 1254 1288 1254 1288 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Brouard et al.<xref ref-type="bibr" rid="CR48">48</xref></td><td char="." align="char">122</td><td align="left">LIA</td><td align="left">0.09</td><td align="left">0%</td><td align="left">54%</td><td align="left">84%</td></tr>
###xml 1303 1305 1303 1305 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR49">49</xref>
###xml 1288 1305 1288 1305 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Vuoristo et al.<xref ref-type="bibr" rid="CR49">49</xref></td>
###xml 1305 1307 1305 1307 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">50</td>
###xml 1307 1310 1307 1310 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">LIA</td>
###xml 1310 1314 1310 1314 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.12</td>
###xml 1314 1315 1314 1315 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8211;</td>
###xml 1315 1316 1315 1316 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8211;</td>
###xml 1316 1321 1316 1321 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">64.0%</td>
###xml 1288 1321 1288 1321 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Vuoristo et al.<xref ref-type="bibr" rid="CR49">49</xref></td><td char="." align="char">50</td><td align="left">LIA</td><td align="left">0.12</td><td align="left">&#8211;</td><td align="left">&#8211;</td><td align="left">64.0%</td></tr>
###xml 1332 1334 1332 1334 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR50">50</xref>
###xml 1321 1334 1321 1334 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Jury et al.<xref ref-type="bibr" rid="CR50">50</xref></td>
###xml 1334 1337 1334 1337 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">214</td>
###xml 1337 1340 1337 1340 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">LIA</td>
###xml 1340 1343 1340 1343 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.2</td>
###xml 1343 1345 1343 1345 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">7%</td>
###xml 1345 1348 1345 1348 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">29%</td>
###xml 1348 1351 1348 1351 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">92%</td>
###xml 1321 1351 1321 1351 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Jury et al.<xref ref-type="bibr" rid="CR50">50</xref></td><td char="." align="char">214</td><td align="left">LIA</td><td align="left">0.2</td><td align="left">7%</td><td align="left">29%</td><td align="left">92%</td></tr>
###xml 1366 1368 1366 1368 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR21">21</xref>
###xml 1351 1368 1351 1368 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Mohammed et al.<xref ref-type="bibr" rid="CR21">21</xref></td>
###xml 1368 1370 1368 1370 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">68</td>
###xml 1370 1373 1370 1373 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">LIA</td>
###xml 1373 1376 1373 1376 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.2</td>
###xml 1376 1377 1376 1377 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8211;</td>
###xml 1377 1378 1377 1378 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8211;</td>
###xml 1378 1383 1378 1383 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">73.5%</td>
###xml 1351 1383 1351 1383 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Mohammed et al.<xref ref-type="bibr" rid="CR21">21</xref></td><td char="." align="char">68</td><td align="left">LIA</td><td align="left">0.2</td><td align="left">&#8211;</td><td align="left">&#8211;</td><td align="left">73.5%</td></tr>
###xml 1399 1401 1399 1401 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR20">20</xref>
###xml 1383 1401 1383 1401 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Martenson et al.<xref ref-type="bibr" rid="CR20">20</xref></td>
###xml 1401 1404 1401 1404 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">727</td>
###xml 1404 1407 1404 1407 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">LIA</td>
###xml 1407 1411 1407 1411 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.10</td>
###xml 1411 1414 1411 1414 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">12%</td>
###xml 1414 1415 1414 1415 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8211;</td>
###xml 1415 1426 1415 1426 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">III/IV: 72%</td>
###xml 1383 1426 1383 1426 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Martenson et al.<xref ref-type="bibr" rid="CR20">20</xref></td><td char="." align="char">727</td><td align="left">LIA</td><td align="left">0.10</td><td align="left">12%</td><td align="left">&#8211;</td><td align="left">III/IV: 72%</td></tr>
###xml 1443 1445 1443 1445 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR51">51</xref>
###xml 1426 1445 1426 1445 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Juergensen et al.<xref ref-type="bibr" rid="CR51">51</xref></td>
###xml 1445 1447 1445 1447 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">50</td>
###xml 1447 1450 1447 1450 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">LIA</td>
###xml 1450 1454 1450 1454 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.12</td>
###xml 1454 1455 1454 1455 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8211;</td>
###xml 1455 1456 1455 1456 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8211;</td>
###xml 1456 1472 1456 1472 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">I/II/III/IV: 50%</td>
###xml 1426 1472 1426 1472 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Juergensen et al.<xref ref-type="bibr" rid="CR51">51</xref></td><td char="." align="char">50</td><td align="left">LIA</td><td align="left">0.12</td><td align="left">&#8211;</td><td align="left">&#8211;</td><td align="left">I/II/III/IV: 50%</td></tr>
###xml 1486 1488 1486 1488 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR52">52</xref>
###xml 1472 1488 1472 1488 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Rebmann et al.<xref ref-type="bibr" rid="CR52">52</xref></td>
###xml 1488 1491 1488 1491 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">183</td>
###xml 1491 1494 1491 1494 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">LIA</td>
###xml 1494 1498 1494 1498 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.12</td>
###xml 1498 1499 1498 1499 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8211;</td>
###xml 1499 1500 1499 1500 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8211;</td>
###xml 1500 1516 1500 1516 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">I/II/III/IV: 21%</td>
###xml 1472 1516 1472 1516 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Rebmann et al.<xref ref-type="bibr" rid="CR52">52</xref></td><td char="." align="char">183</td><td align="left">LIA</td><td align="left">0.12</td><td align="left">&#8211;</td><td align="left">&#8211;</td><td align="left">I/II/III/IV: 21%</td></tr>
###xml 1531 1533 1531 1533 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR30">30</xref>
###xml 1516 1533 1516 1533 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Banfalvi et al.<xref ref-type="bibr" rid="CR30">30</xref></td>
###xml 1533 1535 1533 1535 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">59</td>
###xml 1535 1538 1535 1538 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">LIA</td>
###xml 1538 1542 1538 1542 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.12</td>
###xml 1542 1545 1542 1545 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">40%</td>
###xml 1545 1548 1545 1548 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">25%</td>
###xml 1548 1551 1548 1551 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">59%</td>
###xml 1516 1551 1516 1551 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Banfalvi et al.<xref ref-type="bibr" rid="CR30">30</xref></td><td char="." align="char">59</td><td align="left">LIA</td><td align="left">0.12</td><td align="left">40%</td><td align="left">25%</td><td align="left">59%</td></tr>
###xml 1563 1565 1563 1565 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR32">32</xref>
###xml 1551 1565 1551 1565 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Garbe et al.<xref ref-type="bibr" rid="CR32">32</xref></td>
###xml 1565 1568 1565 1568 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">296</td>
###xml 1568 1571 1568 1571 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">LIA</td>
###xml 1571 1575 1571 1575 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.12</td>
###xml 1575 1575 1575 1575 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 1575 1575 1575 1575 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 1575 1575 1575 1575 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 1551 1575 1551 1575 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Garbe et al.<xref ref-type="bibr" rid="CR32">32</xref></td><td char="." align="char">296</td><td align="left">LIA</td><td align="left">0.12</td><td align="left"/><td align="left"/><td align="left"/></tr>
###xml 1590 1592 1590 1592 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR31">31</xref>
###xml 1575 1592 1575 1592 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Banfalvi et al.<xref ref-type="bibr" rid="CR31">31</xref></td>
###xml 1592 1595 1592 1595 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">478</td>
###xml 1595 1598 1595 1598 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">LIA</td>
###xml 1598 1602 1598 1602 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.18</td>
###xml 1602 1617 1602 1617 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">I: 29%, II: 19%</td>
###xml 1617 1620 1617 1620 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">32%</td>
###xml 1620 1623 1620 1623 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">48%</td>
###xml 1575 1623 1575 1623 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Banfalvi et al.<xref ref-type="bibr" rid="CR31">31</xref></td><td char="." align="char">478</td><td align="left">LIA</td><td align="left">0.18</td><td align="left">I: 29%, II: 19%</td><td align="left">32%</td><td align="left">48%</td></tr>
###xml 1636 1638 1636 1638 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR53">53</xref>
###xml 1623 1638 1623 1638 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Andres et al.<xref ref-type="bibr" rid="CR53">53</xref></td>
###xml 1638 1640 1638 1640 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">85</td>
###xml 1640 1643 1640 1643 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">LIA</td>
###xml 1643 1647 1643 1647 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.15</td>
###xml 1647 1648 1647 1648 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8211;</td>
###xml 1648 1661 1648 1661 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">I/II/III: 15%</td>
###xml 1661 1664 1661 1664 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">89%</td>
###xml 1623 1664 1623 1664 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Andres et al.<xref ref-type="bibr" rid="CR53">53</xref></td><td char="." align="char">85</td><td align="left">LIA</td><td align="left">0.15</td><td align="left">&#8211;</td><td align="left">I/II/III: 15%</td><td align="left">89%</td></tr>
###xml 1677 1679 1677 1679 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR54">54</xref>
###xml 1664 1679 1664 1679 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Ugurel et al.<xref ref-type="bibr" rid="CR54">54</xref></td>
###xml 1679 1682 1679 1682 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">300</td>
###xml 1682 1685 1682 1685 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">LIA</td>
###xml 1685 1689 1685 1689 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.12</td>
###xml 1689 1690 1689 1690 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8211;</td>
###xml 1690 1691 1690 1691 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8211;</td>
###xml 1691 1707 1691 1707 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">I/II/III/IV: 20%</td>
###xml 1664 1707 1664 1707 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Ugurel et al.<xref ref-type="bibr" rid="CR54">54</xref></td><td char="." align="char">300</td><td align="left">LIA</td><td align="left">0.12</td><td align="left">&#8211;</td><td align="left">&#8211;</td><td align="left">I/II/III/IV: 20%</td></tr>
###xml 1718 1720 1718 1720 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR15">15</xref>
###xml 1707 1720 1707 1720 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Smit et al.<xref ref-type="bibr" rid="CR15">15</xref></td>
###xml 1720 1723 1720 1723 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">145</td>
###xml 1723 1726 1723 1726 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">LIA</td>
###xml 1726 1730 1726 1730 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.16</td>
###xml 1730 1731 1730 1731 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8211;</td>
###xml 1731 1732 1731 1732 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8211;</td>
###xml 1732 1735 1732 1735 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">78%</td>
###xml 1707 1735 1707 1735 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Smit et al.<xref ref-type="bibr" rid="CR15">15</xref></td><td char="." align="char">145</td><td align="left">LIA</td><td align="left">0.16</td><td align="left">&#8211;</td><td align="left">&#8211;</td><td align="left">78%</td></tr>
###xml 1749 1751 1749 1751 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR55">55</xref>
###xml 1735 1751 1735 1751 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Schmidt et al.<xref ref-type="bibr" rid="CR55">55</xref></td>
###xml 1751 1753 1751 1753 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">85</td>
###xml 1753 1756 1753 1756 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">LIA</td>
###xml 1756 1760 1756 1760 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.15</td>
###xml 1760 1761 1760 1761 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8211;</td>
###xml 1761 1762 1761 1762 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8211;</td>
###xml 1762 1765 1762 1765 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">59%</td>
###xml 1735 1765 1735 1765 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Schmidt et al.<xref ref-type="bibr" rid="CR55">55</xref></td><td char="." align="char">85</td><td align="left">LIA</td><td align="left">0.15</td><td align="left">&#8211;</td><td align="left">&#8211;</td><td align="left">59%</td></tr>
###xml 1779 1781 1779 1781 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR33">33</xref>
###xml 1765 1781 1765 1781 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Domingo et al.<xref ref-type="bibr" rid="CR33">33</xref></td>
###xml 1781 1783 1781 1783 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">97</td>
###xml 1783 1786 1783 1786 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">LIA</td>
###xml 1786 1790 1786 1790 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.15</td>
###xml 1790 1791 1790 1791 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8211;</td>
###xml 1791 1802 1791 1802 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">II/III: 21%</td>
###xml 1802 1803 1802 1803 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8211;</td>
###xml 1765 1803 1765 1803 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Domingo et al.<xref ref-type="bibr" rid="CR33">33</xref></td><td char="." align="char">97</td><td align="left">LIA</td><td align="left">0.15</td><td align="left">&#8211;</td><td align="left">II/III: 21%</td><td align="left">&#8211;</td></tr>
###xml 1813 1815 1813 1815 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR56">56</xref>
###xml 1803 1815 1803 1815 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Cao et al.<xref ref-type="bibr" rid="CR56">56</xref></td>
###xml 1815 1817 1815 1817 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">42</td>
###xml 1817 1820 1817 1820 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">LIA</td>
###xml 1820 1824 1820 1824 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.20</td>
###xml 1824 1825 1824 1825 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8211;</td>
###xml 1825 1826 1825 1826 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8211;</td>
###xml 1826 1829 1826 1829 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">50%</td>
###xml 1803 1829 1803 1829 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Cao et al.<xref ref-type="bibr" rid="CR56">56</xref></td><td char="." align="char">42</td><td align="left">LIA</td><td align="left">0.20</td><td align="left">&#8211;</td><td align="left">&#8211;</td><td align="left">50%</td></tr>
###xml 1843 1845 1843 1845 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR37">37</xref>
###xml 1829 1845 1829 1845 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Tarhini et al.<xref ref-type="bibr" rid="CR37">37</xref></td>
###xml 1845 1848 1845 1848 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">670</td>
###xml 1848 1851 1848 1851 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">LIA</td>
###xml 1851 1855 1851 1855 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.15</td>
###xml 1855 1856 1855 1856 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8211;</td>
###xml 1856 1868 1856 1868 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">IIb/III: 13%</td>
###xml 1868 1869 1868 1869 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8211;</td>
###xml 1829 1869 1829 1869 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Tarhini et al.<xref ref-type="bibr" rid="CR37">37</xref></td><td char="." align="char">670</td><td align="left">LIA</td><td align="left">0.15</td><td align="left">&#8211;</td><td align="left">IIb/III: 13%</td><td align="left">&#8211;</td></tr>
###xml 1869 1888 1869 1888 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Kruijff et al. 2009</td>
###xml 1888 1890 1888 1890 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">56</td>
###xml 1890 1893 1890 1893 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">LIA</td>
###xml 1893 1897 1893 1897 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.15</td>
###xml 1897 1898 1897 1898 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8211;</td>
###xml 1898 1901 1898 1901 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">48%</td>
###xml 1901 1902 1901 1902 <td xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#8211;</td>
###xml 1869 1902 1869 1902 <tr xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Kruijff et al. 2009</td><td char="." align="char">56</td><td align="left">LIA</td><td align="left">0.15</td><td align="left">&#8211;</td><td align="left">48%</td><td align="left">&#8211;</td></tr>
###xml 730 1902 730 1902 <tbody xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td align="left">Guo et al.<xref ref-type="bibr" rid="CR14">14</xref></td><td char="." align="char">126</td><td align="left">IRMA</td><td align="left">0.15</td><td align="left">1%</td><td align="left">9%</td><td align="left">74%</td></tr><tr><td align="left">Miliotes et al.<xref ref-type="bibr" rid="CR38">38</xref></td><td char="." align="char">67</td><td align="left">IRMA</td><td align="left">0.05</td><td align="left">47.8%</td><td align="left">&#8211;</td><td align="left">&#8211;</td></tr><tr><td align="left">Abraha et al.<xref ref-type="bibr" rid="CR39">39</xref></td><td char="." align="char">97</td><td align="left">IRMA</td><td align="left">0.2</td><td align="left">9%</td><td align="left">82%</td><td align="left">&#8211;</td></tr><tr><td align="left">Bosserhoff et al.<xref ref-type="bibr" rid="CR40">40</xref></td><td char="." align="char">112</td><td align="left">IRMA</td><td align="left">0.15</td><td align="left">0%</td><td align="left">62%</td><td align="left">&#8211;</td></tr><tr><td align="left">Buer et al.<xref ref-type="bibr" rid="CR24">24</xref></td><td char="." align="char">99</td><td align="left">IRMA</td><td align="left">3.00</td><td align="left">&#8211;</td><td align="left">&#8211;</td><td align="left">22.2%</td></tr><tr><td align="left">Henze et al.<xref ref-type="bibr" rid="CR29">29</xref></td><td char="." align="char">73</td><td align="left">IRMA</td><td align="left">0.3</td><td align="left">4%</td><td align="left">21%</td><td align="left">79%</td></tr><tr><td align="left">Tofani et al.<xref ref-type="bibr" rid="CR41">41</xref></td><td char="." align="char">53</td><td align="left">IRMA</td><td align="left">0.5</td><td align="left">0%</td><td align="left">55%</td><td align="left">&#8211;</td></tr><tr><td align="left">Schultz et al.<xref ref-type="bibr" rid="CR42">42</xref></td><td char="." align="char">84</td><td align="left">IRMA</td><td align="left">0.3</td><td align="left">0%</td><td align="left">31%</td><td align="left">69%</td></tr><tr><td align="left">Bonfrer et al.<xref ref-type="bibr" rid="CR43">43</xref></td><td char="." align="char">251</td><td align="left">LIA</td><td align="left">0.16</td><td align="left">I/II: 1%</td><td align="left">&#8211;</td><td align="left">III/IV: 79%</td></tr><tr><td align="left">Seregni et al.<xref ref-type="bibr" rid="CR44">44</xref></td><td char="." align="char">438</td><td align="left">IRMA</td><td align="left">0.2</td><td align="left">I: 4.2%, II: 5.3%</td><td align="left">38.5%</td><td align="left">&#8211;</td></tr><tr><td align="left">Hauschild et al.<xref ref-type="bibr" rid="CR45">45</xref></td><td char="." align="char">412</td><td align="left">IRMA</td><td align="left">0.2</td><td align="left">2%</td><td align="left">19%</td><td align="left">68%</td></tr><tr><td align="left">Curry et al.<xref ref-type="bibr" rid="CR22">22</xref></td><td char="." align="char">147</td><td align="left">IRMA/LIA</td><td align="left">0.2/0.12</td><td align="left">&#8211;</td><td align="left">23%/47.5%</td><td align="left">&#8211;</td></tr><tr><td align="left">Berking et al.<xref ref-type="bibr" rid="CR46">46</xref></td><td char="." align="char">352</td><td align="left">LIA</td><td align="left">0.2</td><td align="left">7%</td><td align="left">8%</td><td align="left">48%</td></tr><tr><td align="left">Jackel et al.<xref ref-type="bibr" rid="CR16">16</xref></td><td char="." align="char">276</td><td align="left">LIA</td><td align="left">0.12</td><td align="left">6%</td><td align="left">5%</td><td align="left">48%</td></tr><tr><td align="left">Kaskel et al.<xref ref-type="bibr" rid="CR47">47</xref></td><td char="." align="char">570</td><td align="left">LIA</td><td align="left">0.11</td><td align="left">9%</td><td align="left">94%</td><td align="left">&#8211;</td></tr><tr><td align="left">Brouard et al.<xref ref-type="bibr" rid="CR48">48</xref></td><td char="." align="char">122</td><td align="left">LIA</td><td align="left">0.09</td><td align="left">0%</td><td align="left">54%</td><td align="left">84%</td></tr><tr><td align="left">Vuoristo et al.<xref ref-type="bibr" rid="CR49">49</xref></td><td char="." align="char">50</td><td align="left">LIA</td><td align="left">0.12</td><td align="left">&#8211;</td><td align="left">&#8211;</td><td align="left">64.0%</td></tr><tr><td align="left">Jury et al.<xref ref-type="bibr" rid="CR50">50</xref></td><td char="." align="char">214</td><td align="left">LIA</td><td align="left">0.2</td><td align="left">7%</td><td align="left">29%</td><td align="left">92%</td></tr><tr><td align="left">Mohammed et al.<xref ref-type="bibr" rid="CR21">21</xref></td><td char="." align="char">68</td><td align="left">LIA</td><td align="left">0.2</td><td align="left">&#8211;</td><td align="left">&#8211;</td><td align="left">73.5%</td></tr><tr><td align="left">Martenson et al.<xref ref-type="bibr" rid="CR20">20</xref></td><td char="." align="char">727</td><td align="left">LIA</td><td align="left">0.10</td><td align="left">12%</td><td align="left">&#8211;</td><td align="left">III/IV: 72%</td></tr><tr><td align="left">Juergensen et al.<xref ref-type="bibr" rid="CR51">51</xref></td><td char="." align="char">50</td><td align="left">LIA</td><td align="left">0.12</td><td align="left">&#8211;</td><td align="left">&#8211;</td><td align="left">I/II/III/IV: 50%</td></tr><tr><td align="left">Rebmann et al.<xref ref-type="bibr" rid="CR52">52</xref></td><td char="." align="char">183</td><td align="left">LIA</td><td align="left">0.12</td><td align="left">&#8211;</td><td align="left">&#8211;</td><td align="left">I/II/III/IV: 21%</td></tr><tr><td align="left">Banfalvi et al.<xref ref-type="bibr" rid="CR30">30</xref></td><td char="." align="char">59</td><td align="left">LIA</td><td align="left">0.12</td><td align="left">40%</td><td align="left">25%</td><td align="left">59%</td></tr><tr><td align="left">Garbe et al.<xref ref-type="bibr" rid="CR32">32</xref></td><td char="." align="char">296</td><td align="left">LIA</td><td align="left">0.12</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">Banfalvi et al.<xref ref-type="bibr" rid="CR31">31</xref></td><td char="." align="char">478</td><td align="left">LIA</td><td align="left">0.18</td><td align="left">I: 29%, II: 19%</td><td align="left">32%</td><td align="left">48%</td></tr><tr><td align="left">Andres et al.<xref ref-type="bibr" rid="CR53">53</xref></td><td char="." align="char">85</td><td align="left">LIA</td><td align="left">0.15</td><td align="left">&#8211;</td><td align="left">I/II/III: 15%</td><td align="left">89%</td></tr><tr><td align="left">Ugurel et al.<xref ref-type="bibr" rid="CR54">54</xref></td><td char="." align="char">300</td><td align="left">LIA</td><td align="left">0.12</td><td align="left">&#8211;</td><td align="left">&#8211;</td><td align="left">I/II/III/IV: 20%</td></tr><tr><td align="left">Smit et al.<xref ref-type="bibr" rid="CR15">15</xref></td><td char="." align="char">145</td><td align="left">LIA</td><td align="left">0.16</td><td align="left">&#8211;</td><td align="left">&#8211;</td><td align="left">78%</td></tr><tr><td align="left">Schmidt et al.<xref ref-type="bibr" rid="CR55">55</xref></td><td char="." align="char">85</td><td align="left">LIA</td><td align="left">0.15</td><td align="left">&#8211;</td><td align="left">&#8211;</td><td align="left">59%</td></tr><tr><td align="left">Domingo et al.<xref ref-type="bibr" rid="CR33">33</xref></td><td char="." align="char">97</td><td align="left">LIA</td><td align="left">0.15</td><td align="left">&#8211;</td><td align="left">II/III: 21%</td><td align="left">&#8211;</td></tr><tr><td align="left">Cao et al.<xref ref-type="bibr" rid="CR56">56</xref></td><td char="." align="char">42</td><td align="left">LIA</td><td align="left">0.20</td><td align="left">&#8211;</td><td align="left">&#8211;</td><td align="left">50%</td></tr><tr><td align="left">Tarhini et al.<xref ref-type="bibr" rid="CR37">37</xref></td><td char="." align="char">670</td><td align="left">LIA</td><td align="left">0.15</td><td align="left">&#8211;</td><td align="left">IIb/III: 13%</td><td align="left">&#8211;</td></tr><tr><td align="left">Kruijff et al. 2009</td><td char="." align="char">56</td><td align="left">LIA</td><td align="left">0.15</td><td align="left">&#8211;</td><td align="left">48%</td><td align="left">&#8211;</td></tr></tbody>
###xml 673 1902 673 1902 <table xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th align="left">Reference</th><th align="left">No.</th><th align="left">Assay</th><th align="left">Cut-off value</th><th align="left">Stage I/II</th><th align="left">Stage III</th><th align="left">Stage IV</th></tr></thead><tbody><tr><td align="left">Guo et al.<xref ref-type="bibr" rid="CR14">14</xref></td><td char="." align="char">126</td><td align="left">IRMA</td><td align="left">0.15</td><td align="left">1%</td><td align="left">9%</td><td align="left">74%</td></tr><tr><td align="left">Miliotes et al.<xref ref-type="bibr" rid="CR38">38</xref></td><td char="." align="char">67</td><td align="left">IRMA</td><td align="left">0.05</td><td align="left">47.8%</td><td align="left">&#8211;</td><td align="left">&#8211;</td></tr><tr><td align="left">Abraha et al.<xref ref-type="bibr" rid="CR39">39</xref></td><td char="." align="char">97</td><td align="left">IRMA</td><td align="left">0.2</td><td align="left">9%</td><td align="left">82%</td><td align="left">&#8211;</td></tr><tr><td align="left">Bosserhoff et al.<xref ref-type="bibr" rid="CR40">40</xref></td><td char="." align="char">112</td><td align="left">IRMA</td><td align="left">0.15</td><td align="left">0%</td><td align="left">62%</td><td align="left">&#8211;</td></tr><tr><td align="left">Buer et al.<xref ref-type="bibr" rid="CR24">24</xref></td><td char="." align="char">99</td><td align="left">IRMA</td><td align="left">3.00</td><td align="left">&#8211;</td><td align="left">&#8211;</td><td align="left">22.2%</td></tr><tr><td align="left">Henze et al.<xref ref-type="bibr" rid="CR29">29</xref></td><td char="." align="char">73</td><td align="left">IRMA</td><td align="left">0.3</td><td align="left">4%</td><td align="left">21%</td><td align="left">79%</td></tr><tr><td align="left">Tofani et al.<xref ref-type="bibr" rid="CR41">41</xref></td><td char="." align="char">53</td><td align="left">IRMA</td><td align="left">0.5</td><td align="left">0%</td><td align="left">55%</td><td align="left">&#8211;</td></tr><tr><td align="left">Schultz et al.<xref ref-type="bibr" rid="CR42">42</xref></td><td char="." align="char">84</td><td align="left">IRMA</td><td align="left">0.3</td><td align="left">0%</td><td align="left">31%</td><td align="left">69%</td></tr><tr><td align="left">Bonfrer et al.<xref ref-type="bibr" rid="CR43">43</xref></td><td char="." align="char">251</td><td align="left">LIA</td><td align="left">0.16</td><td align="left">I/II: 1%</td><td align="left">&#8211;</td><td align="left">III/IV: 79%</td></tr><tr><td align="left">Seregni et al.<xref ref-type="bibr" rid="CR44">44</xref></td><td char="." align="char">438</td><td align="left">IRMA</td><td align="left">0.2</td><td align="left">I: 4.2%, II: 5.3%</td><td align="left">38.5%</td><td align="left">&#8211;</td></tr><tr><td align="left">Hauschild et al.<xref ref-type="bibr" rid="CR45">45</xref></td><td char="." align="char">412</td><td align="left">IRMA</td><td align="left">0.2</td><td align="left">2%</td><td align="left">19%</td><td align="left">68%</td></tr><tr><td align="left">Curry et al.<xref ref-type="bibr" rid="CR22">22</xref></td><td char="." align="char">147</td><td align="left">IRMA/LIA</td><td align="left">0.2/0.12</td><td align="left">&#8211;</td><td align="left">23%/47.5%</td><td align="left">&#8211;</td></tr><tr><td align="left">Berking et al.<xref ref-type="bibr" rid="CR46">46</xref></td><td char="." align="char">352</td><td align="left">LIA</td><td align="left">0.2</td><td align="left">7%</td><td align="left">8%</td><td align="left">48%</td></tr><tr><td align="left">Jackel et al.<xref ref-type="bibr" rid="CR16">16</xref></td><td char="." align="char">276</td><td align="left">LIA</td><td align="left">0.12</td><td align="left">6%</td><td align="left">5%</td><td align="left">48%</td></tr><tr><td align="left">Kaskel et al.<xref ref-type="bibr" rid="CR47">47</xref></td><td char="." align="char">570</td><td align="left">LIA</td><td align="left">0.11</td><td align="left">9%</td><td align="left">94%</td><td align="left">&#8211;</td></tr><tr><td align="left">Brouard et al.<xref ref-type="bibr" rid="CR48">48</xref></td><td char="." align="char">122</td><td align="left">LIA</td><td align="left">0.09</td><td align="left">0%</td><td align="left">54%</td><td align="left">84%</td></tr><tr><td align="left">Vuoristo et al.<xref ref-type="bibr" rid="CR49">49</xref></td><td char="." align="char">50</td><td align="left">LIA</td><td align="left">0.12</td><td align="left">&#8211;</td><td align="left">&#8211;</td><td align="left">64.0%</td></tr><tr><td align="left">Jury et al.<xref ref-type="bibr" rid="CR50">50</xref></td><td char="." align="char">214</td><td align="left">LIA</td><td align="left">0.2</td><td align="left">7%</td><td align="left">29%</td><td align="left">92%</td></tr><tr><td align="left">Mohammed et al.<xref ref-type="bibr" rid="CR21">21</xref></td><td char="." align="char">68</td><td align="left">LIA</td><td align="left">0.2</td><td align="left">&#8211;</td><td align="left">&#8211;</td><td align="left">73.5%</td></tr><tr><td align="left">Martenson et al.<xref ref-type="bibr" rid="CR20">20</xref></td><td char="." align="char">727</td><td align="left">LIA</td><td align="left">0.10</td><td align="left">12%</td><td align="left">&#8211;</td><td align="left">III/IV: 72%</td></tr><tr><td align="left">Juergensen et al.<xref ref-type="bibr" rid="CR51">51</xref></td><td char="." align="char">50</td><td align="left">LIA</td><td align="left">0.12</td><td align="left">&#8211;</td><td align="left">&#8211;</td><td align="left">I/II/III/IV: 50%</td></tr><tr><td align="left">Rebmann et al.<xref ref-type="bibr" rid="CR52">52</xref></td><td char="." align="char">183</td><td align="left">LIA</td><td align="left">0.12</td><td align="left">&#8211;</td><td align="left">&#8211;</td><td align="left">I/II/III/IV: 21%</td></tr><tr><td align="left">Banfalvi et al.<xref ref-type="bibr" rid="CR30">30</xref></td><td char="." align="char">59</td><td align="left">LIA</td><td align="left">0.12</td><td align="left">40%</td><td align="left">25%</td><td align="left">59%</td></tr><tr><td align="left">Garbe et al.<xref ref-type="bibr" rid="CR32">32</xref></td><td char="." align="char">296</td><td align="left">LIA</td><td align="left">0.12</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">Banfalvi et al.<xref ref-type="bibr" rid="CR31">31</xref></td><td char="." align="char">478</td><td align="left">LIA</td><td align="left">0.18</td><td align="left">I: 29%, II: 19%</td><td align="left">32%</td><td align="left">48%</td></tr><tr><td align="left">Andres et al.<xref ref-type="bibr" rid="CR53">53</xref></td><td char="." align="char">85</td><td align="left">LIA</td><td align="left">0.15</td><td align="left">&#8211;</td><td align="left">I/II/III: 15%</td><td align="left">89%</td></tr><tr><td align="left">Ugurel et al.<xref ref-type="bibr" rid="CR54">54</xref></td><td char="." align="char">300</td><td align="left">LIA</td><td align="left">0.12</td><td align="left">&#8211;</td><td align="left">&#8211;</td><td align="left">I/II/III/IV: 20%</td></tr><tr><td align="left">Smit et al.<xref ref-type="bibr" rid="CR15">15</xref></td><td char="." align="char">145</td><td align="left">LIA</td><td align="left">0.16</td><td align="left">&#8211;</td><td align="left">&#8211;</td><td align="left">78%</td></tr><tr><td align="left">Schmidt et al.<xref ref-type="bibr" rid="CR55">55</xref></td><td char="." align="char">85</td><td align="left">LIA</td><td align="left">0.15</td><td align="left">&#8211;</td><td align="left">&#8211;</td><td align="left">59%</td></tr><tr><td align="left">Domingo et al.<xref ref-type="bibr" rid="CR33">33</xref></td><td char="." align="char">97</td><td align="left">LIA</td><td align="left">0.15</td><td align="left">&#8211;</td><td align="left">II/III: 21%</td><td align="left">&#8211;</td></tr><tr><td align="left">Cao et al.<xref ref-type="bibr" rid="CR56">56</xref></td><td char="." align="char">42</td><td align="left">LIA</td><td align="left">0.20</td><td align="left">&#8211;</td><td align="left">&#8211;</td><td align="left">50%</td></tr><tr><td align="left">Tarhini et al.<xref ref-type="bibr" rid="CR37">37</xref></td><td char="." align="char">670</td><td align="left">LIA</td><td align="left">0.15</td><td align="left">&#8211;</td><td align="left">IIb/III: 13%</td><td align="left">&#8211;</td></tr><tr><td align="left">Kruijff et al. 2009</td><td char="." align="char">56</td><td align="left">LIA</td><td align="left">0.15</td><td align="left">&#8211;</td><td align="left">48%</td><td align="left">&#8211;</td></tr></tbody></table>
###xml 1902 1905 1902 1905 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">LIA</italic>
###xml 1933 1937 1933 1937 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">IRMA</italic>
###xml 1902 1962 1902 1962 <p xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" textid="40"><italic>LIA</italic> lumino immunometric assay, <italic>IRMA</italic> immuno radiometric assay</p>
###xml 1902 1962 1902 1962 <table-wrap-foot xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="40"><italic>LIA</italic> lumino immunometric assay, <italic>IRMA</italic> immuno radiometric assay</p></table-wrap-foot>
###xml 594 1962 594 1962 <table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab4"><label>Table&#160;4</label><caption><p textid="39">Review literature S-100B values above cut-off point in melanoma patients</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Reference</th><th align="left">No.</th><th align="left">Assay</th><th align="left">Cut-off value</th><th align="left">Stage I/II</th><th align="left">Stage III</th><th align="left">Stage IV</th></tr></thead><tbody><tr><td align="left">Guo et al.<xref ref-type="bibr" rid="CR14">14</xref></td><td char="." align="char">126</td><td align="left">IRMA</td><td align="left">0.15</td><td align="left">1%</td><td align="left">9%</td><td align="left">74%</td></tr><tr><td align="left">Miliotes et al.<xref ref-type="bibr" rid="CR38">38</xref></td><td char="." align="char">67</td><td align="left">IRMA</td><td align="left">0.05</td><td align="left">47.8%</td><td align="left">&#8211;</td><td align="left">&#8211;</td></tr><tr><td align="left">Abraha et al.<xref ref-type="bibr" rid="CR39">39</xref></td><td char="." align="char">97</td><td align="left">IRMA</td><td align="left">0.2</td><td align="left">9%</td><td align="left">82%</td><td align="left">&#8211;</td></tr><tr><td align="left">Bosserhoff et al.<xref ref-type="bibr" rid="CR40">40</xref></td><td char="." align="char">112</td><td align="left">IRMA</td><td align="left">0.15</td><td align="left">0%</td><td align="left">62%</td><td align="left">&#8211;</td></tr><tr><td align="left">Buer et al.<xref ref-type="bibr" rid="CR24">24</xref></td><td char="." align="char">99</td><td align="left">IRMA</td><td align="left">3.00</td><td align="left">&#8211;</td><td align="left">&#8211;</td><td align="left">22.2%</td></tr><tr><td align="left">Henze et al.<xref ref-type="bibr" rid="CR29">29</xref></td><td char="." align="char">73</td><td align="left">IRMA</td><td align="left">0.3</td><td align="left">4%</td><td align="left">21%</td><td align="left">79%</td></tr><tr><td align="left">Tofani et al.<xref ref-type="bibr" rid="CR41">41</xref></td><td char="." align="char">53</td><td align="left">IRMA</td><td align="left">0.5</td><td align="left">0%</td><td align="left">55%</td><td align="left">&#8211;</td></tr><tr><td align="left">Schultz et al.<xref ref-type="bibr" rid="CR42">42</xref></td><td char="." align="char">84</td><td align="left">IRMA</td><td align="left">0.3</td><td align="left">0%</td><td align="left">31%</td><td align="left">69%</td></tr><tr><td align="left">Bonfrer et al.<xref ref-type="bibr" rid="CR43">43</xref></td><td char="." align="char">251</td><td align="left">LIA</td><td align="left">0.16</td><td align="left">I/II: 1%</td><td align="left">&#8211;</td><td align="left">III/IV: 79%</td></tr><tr><td align="left">Seregni et al.<xref ref-type="bibr" rid="CR44">44</xref></td><td char="." align="char">438</td><td align="left">IRMA</td><td align="left">0.2</td><td align="left">I: 4.2%, II: 5.3%</td><td align="left">38.5%</td><td align="left">&#8211;</td></tr><tr><td align="left">Hauschild et al.<xref ref-type="bibr" rid="CR45">45</xref></td><td char="." align="char">412</td><td align="left">IRMA</td><td align="left">0.2</td><td align="left">2%</td><td align="left">19%</td><td align="left">68%</td></tr><tr><td align="left">Curry et al.<xref ref-type="bibr" rid="CR22">22</xref></td><td char="." align="char">147</td><td align="left">IRMA/LIA</td><td align="left">0.2/0.12</td><td align="left">&#8211;</td><td align="left">23%/47.5%</td><td align="left">&#8211;</td></tr><tr><td align="left">Berking et al.<xref ref-type="bibr" rid="CR46">46</xref></td><td char="." align="char">352</td><td align="left">LIA</td><td align="left">0.2</td><td align="left">7%</td><td align="left">8%</td><td align="left">48%</td></tr><tr><td align="left">Jackel et al.<xref ref-type="bibr" rid="CR16">16</xref></td><td char="." align="char">276</td><td align="left">LIA</td><td align="left">0.12</td><td align="left">6%</td><td align="left">5%</td><td align="left">48%</td></tr><tr><td align="left">Kaskel et al.<xref ref-type="bibr" rid="CR47">47</xref></td><td char="." align="char">570</td><td align="left">LIA</td><td align="left">0.11</td><td align="left">9%</td><td align="left">94%</td><td align="left">&#8211;</td></tr><tr><td align="left">Brouard et al.<xref ref-type="bibr" rid="CR48">48</xref></td><td char="." align="char">122</td><td align="left">LIA</td><td align="left">0.09</td><td align="left">0%</td><td align="left">54%</td><td align="left">84%</td></tr><tr><td align="left">Vuoristo et al.<xref ref-type="bibr" rid="CR49">49</xref></td><td char="." align="char">50</td><td align="left">LIA</td><td align="left">0.12</td><td align="left">&#8211;</td><td align="left">&#8211;</td><td align="left">64.0%</td></tr><tr><td align="left">Jury et al.<xref ref-type="bibr" rid="CR50">50</xref></td><td char="." align="char">214</td><td align="left">LIA</td><td align="left">0.2</td><td align="left">7%</td><td align="left">29%</td><td align="left">92%</td></tr><tr><td align="left">Mohammed et al.<xref ref-type="bibr" rid="CR21">21</xref></td><td char="." align="char">68</td><td align="left">LIA</td><td align="left">0.2</td><td align="left">&#8211;</td><td align="left">&#8211;</td><td align="left">73.5%</td></tr><tr><td align="left">Martenson et al.<xref ref-type="bibr" rid="CR20">20</xref></td><td char="." align="char">727</td><td align="left">LIA</td><td align="left">0.10</td><td align="left">12%</td><td align="left">&#8211;</td><td align="left">III/IV: 72%</td></tr><tr><td align="left">Juergensen et al.<xref ref-type="bibr" rid="CR51">51</xref></td><td char="." align="char">50</td><td align="left">LIA</td><td align="left">0.12</td><td align="left">&#8211;</td><td align="left">&#8211;</td><td align="left">I/II/III/IV: 50%</td></tr><tr><td align="left">Rebmann et al.<xref ref-type="bibr" rid="CR52">52</xref></td><td char="." align="char">183</td><td align="left">LIA</td><td align="left">0.12</td><td align="left">&#8211;</td><td align="left">&#8211;</td><td align="left">I/II/III/IV: 21%</td></tr><tr><td align="left">Banfalvi et al.<xref ref-type="bibr" rid="CR30">30</xref></td><td char="." align="char">59</td><td align="left">LIA</td><td align="left">0.12</td><td align="left">40%</td><td align="left">25%</td><td align="left">59%</td></tr><tr><td align="left">Garbe et al.<xref ref-type="bibr" rid="CR32">32</xref></td><td char="." align="char">296</td><td align="left">LIA</td><td align="left">0.12</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">Banfalvi et al.<xref ref-type="bibr" rid="CR31">31</xref></td><td char="." align="char">478</td><td align="left">LIA</td><td align="left">0.18</td><td align="left">I: 29%, II: 19%</td><td align="left">32%</td><td align="left">48%</td></tr><tr><td align="left">Andres et al.<xref ref-type="bibr" rid="CR53">53</xref></td><td char="." align="char">85</td><td align="left">LIA</td><td align="left">0.15</td><td align="left">&#8211;</td><td align="left">I/II/III: 15%</td><td align="left">89%</td></tr><tr><td align="left">Ugurel et al.<xref ref-type="bibr" rid="CR54">54</xref></td><td char="." align="char">300</td><td align="left">LIA</td><td align="left">0.12</td><td align="left">&#8211;</td><td align="left">&#8211;</td><td align="left">I/II/III/IV: 20%</td></tr><tr><td align="left">Smit et al.<xref ref-type="bibr" rid="CR15">15</xref></td><td char="." align="char">145</td><td align="left">LIA</td><td align="left">0.16</td><td align="left">&#8211;</td><td align="left">&#8211;</td><td align="left">78%</td></tr><tr><td align="left">Schmidt et al.<xref ref-type="bibr" rid="CR55">55</xref></td><td char="." align="char">85</td><td align="left">LIA</td><td align="left">0.15</td><td align="left">&#8211;</td><td align="left">&#8211;</td><td align="left">59%</td></tr><tr><td align="left">Domingo et al.<xref ref-type="bibr" rid="CR33">33</xref></td><td char="." align="char">97</td><td align="left">LIA</td><td align="left">0.15</td><td align="left">&#8211;</td><td align="left">II/III: 21%</td><td align="left">&#8211;</td></tr><tr><td align="left">Cao et al.<xref ref-type="bibr" rid="CR56">56</xref></td><td char="." align="char">42</td><td align="left">LIA</td><td align="left">0.20</td><td align="left">&#8211;</td><td align="left">&#8211;</td><td align="left">50%</td></tr><tr><td align="left">Tarhini et al.<xref ref-type="bibr" rid="CR37">37</xref></td><td char="." align="char">670</td><td align="left">LIA</td><td align="left">0.15</td><td align="left">&#8211;</td><td align="left">IIb/III: 13%</td><td align="left">&#8211;</td></tr><tr><td align="left">Kruijff et al. 2009</td><td char="." align="char">56</td><td align="left">LIA</td><td align="left">0.15</td><td align="left">&#8211;</td><td align="left">48%</td><td align="left">&#8211;</td></tr></tbody></table><table-wrap-foot><p textid="40"><italic>LIA</italic> lumino immunometric assay, <italic>IRMA</italic> immuno radiometric assay</p></table-wrap-foot></table-wrap>
###xml 112 120 <span type="species:ncbi:9606">patients</span>
###xml 267 275 <span type="species:ncbi:9606">patients</span>
###xml 449 457 <span type="species:ncbi:9606">patients</span>
This is the first study that demonstrates a potential prognostic value of preoperative S-100B concentrations in patients who underwent a therapeutic lymph node dissection after preoperative staging with FDG-PET and CT. According to the literature, the proportions of patients with elevated S-100B concentrations were 0-9% in stage I/II, 5-98% in stage III, and 40-100% in stage IV melanoma (Table 4). The highest S-100B concentrations were found in patients with liver and/or skeletal metastases.20,21 Serum S-100B concentrations are therefore correlated with the clinical stage of the disease.Table 4Review literature S-100B values above cut-off point in melanoma patientsReferenceNo.AssayCut-off valueStage I/IIStage IIIStage IVGuo et al.14126IRMA0.151%9%74%Miliotes et al.3867IRMA0.0547.8%--Abraha et al.3997IRMA0.29%82%-Bosserhoff et al.40112IRMA0.150%62%-Buer et al.2499IRMA3.00--22.2%Henze et al.2973IRMA0.34%21%79%Tofani et al.4153IRMA0.50%55%-Schultz et al.4284IRMA0.30%31%69%Bonfrer et al.43251LIA0.16I/II: 1%-III/IV: 79%Seregni et al.44438IRMA0.2I: 4.2%, II: 5.3%38.5%-Hauschild et al.45412IRMA0.22%19%68%Curry et al.22147IRMA/LIA0.2/0.12-23%/47.5%-Berking et al.46352LIA0.27%8%48%Jackel et al.16276LIA0.126%5%48%Kaskel et al.47570LIA0.119%94%-Brouard et al.48122LIA0.090%54%84%Vuoristo et al.4950LIA0.12--64.0%Jury et al.50214LIA0.27%29%92%Mohammed et al.2168LIA0.2--73.5%Martenson et al.20727LIA0.1012%-III/IV: 72%Juergensen et al.5150LIA0.12--I/II/III/IV: 50%Rebmann et al.52183LIA0.12--I/II/III/IV: 21%Banfalvi et al.3059LIA0.1240%25%59%Garbe et al.32296LIA0.12Banfalvi et al.31478LIA0.18I: 29%, II: 19%32%48%Andres et al.5385LIA0.15-I/II/III: 15%89%Ugurel et al.54300LIA0.12--I/II/III/IV: 20%Smit et al.15145LIA0.16--78%Schmidt et al.5585LIA0.15--59%Domingo et al.3397LIA0.15-II/III: 21%-Cao et al.5642LIA0.20--50%Tarhini et al.37670LIA0.15-IIb/III: 13%-Kruijff et al. 200956LIA0.15-48%-LIA lumino immunometric assay, IRMA immuno radiometric assay
###end p 38
###begin p 39
###xml 64 72 <span type="species:ncbi:9606">patients</span>
Review literature S-100B values above cut-off point in melanoma patients
###end p 39
###begin p 40
###xml 0 3 0 3 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">LIA</italic>
###xml 31 35 31 35 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">IRMA</italic>
LIA lumino immunometric assay, IRMA immuno radiometric assay
###end p 40
###begin p 41
###xml 660 661 660 661 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab4" ref-type="table">4</xref>
###xml 663 664 663 664 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR8">8</xref>
###xml 876 877 876 877 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR2">2</xref>
###xml 1034 1036 1034 1036 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR20">20</xref>
###xml 1037 1039 1037 1039 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR22">22</xref>
###xml 1141 1143 1141 1143 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR20">20</xref>
###xml 1144 1146 1144 1146 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR23">23</xref>
###xml 1147 1149 1147 1149 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR25">25</xref>
###xml 1302 1304 1302 1304 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR15">15</xref>
###xml 1305 1307 1305 1307 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR26">26</xref>
###xml 1444 1446 1444 1446 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR14">14</xref>
###xml 1447 1449 1447 1449 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR27">27</xref>
###xml 1450 1452 1450 1452 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR29">29</xref>
###xml 1766 1768 1766 1768 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR20">20</xref>
###xml 1819 1821 1819 1821 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR30">30</xref>
###xml 1822 1824 1822 1824 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR31">31</xref>
###xml 1949 1951 1949 1951 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR30">30</xref>
###xml 1952 1954 1952 1954 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR31">31</xref>
###xml 168 176 <span type="species:ncbi:9606">patients</span>
###xml 514 522 <span type="species:ncbi:9606">patients</span>
###xml 612 620 <span type="species:ncbi:9606">patients</span>
###xml 770 778 <span type="species:ncbi:9606">patients</span>
###xml 1162 1170 <span type="species:ncbi:9606">patients</span>
###xml 1222 1230 <span type="species:ncbi:9606">patients</span>
###xml 1356 1364 <span type="species:ncbi:9606">patients</span>
###xml 1481 1489 <span type="species:ncbi:9606">patients</span>
###xml 1667 1675 <span type="species:ncbi:9606">patients</span>
The aim of this study was to evaluate the prognostic value of preoperative and postoperative concentrations of the tumor marker S-100B in clinically stage III melanoma patients who underwent a so-called "curative lymph node dissection" after preoperative staging with whole-body FDG-PET and spiral CT. Our results showed that preoperative elevated concentrations of S-100B was statistically significantly associated with a decreased DFS. It is difficult to compare the studies investigating the value of S-100B in patients with melanoma, because various assays (IRMA or LIA-mat) and cut-off points and groups of patients with different stages were used (Table 4).8 Garbe et al. also found a relation between S-100B and disease-free survival in stage II and III melanoma patients. Postoperative elevated S-100B preceded detection of developing metastases by imaging techniques.2 According to Martenson et al. and Curry et al., elevated S-100B in stage III melanoma after lymph node dissection may form an independent prognostic factor.20,22 Four studies demonstrated that elevated S-100B was associated with shortened (disease-free) survival.20,23-25 In stage IV patients with normal S-100B levels, survival was better for patients with low S-100B levels compared with those with elevated S-100B levels.15,26 Increasing concentrations of S-100B in stage IV patients who were receiving systemic treatment were associated with disease progression.14,27-29 In a study on 1007 melanoma patients, S-100B was not only correlated with the clinical stage of the disease, but it also appeared to be an independent prognostic marker in stages II and III. The 5-year survival of patients with S-100B values of <0.10 g/L was 91%, compared with 51% when the values were >0.10 g/L.20 In two other studies, similar patterns were found.30,31 Two studies comparing 5-S-cysteinyldopa, LDH and S-100B as prognostic markers found that S-100B had the highest specificity.30,31
###end p 41
###begin p 42
###xml 411 413 411 413 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR14">14</xref>
###xml 414 416 414 416 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR27">27</xref>
###xml 417 419 417 419 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR28">28</xref>
###xml 134 142 <span type="species:ncbi:9606">patients</span>
###xml 193 201 <span type="species:ncbi:9606">patients</span>
Several studies have therefore recommended the use of S-100B as a tumor marker to monitor the course of disease in stage III melanoma patients and to evaluate the effect of therapy in stage IV patients. Successful treatment with lymph node dissection, chemotherapy, or immunotherapy was associated with decreased S-100B concentrations, whereas increased concentrations were an expression of disease progression.14,27,28
###end p 42
###begin p 43
###xml 765 766 765 766 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 120 128 <span type="species:ncbi:9606">patients</span>
###xml 416 424 <span type="species:ncbi:9606">patients</span>
###xml 561 569 <span type="species:ncbi:9606">patients</span>
The prognostic value of the preoperative and postoperative course of S-100B concentrations in "true stage III" melanoma patients has not been studied before. In advance, we hypothesized that a significant decrease in S-100B concentration after therapeutic lymph node dissection would correlate with better DFS. In this way we assumed S-100B could be used as a quality-control marker for dissection. In our study, 27 patients (48.2%) had elevated S-100B preoperatively, and indeed in 22 of them (81.4%) the concentrations normalized postoperatively. However, 12 patients of these 22 (55%) developed tumor recurrence during a median follow-up of 1.18 years. Multivariate analyses showed that preoperative S-100B elevation was an important predictor of decreased DFS (P = .03).
###end p 43
###begin p 44
Although the results indicated that therapeutic lymph node dissection did have a temporary influence on the postoperative course of S-100B, a more important predictor for shortened DFS seemed preoperative S-100B elevation. For AJCC stage III, postoperative increasing S-100B serum were associated with a decreased DFS. However, when adjusted for stage III substages, probably because of small numbers, only a trend toward statistical significance was observed.
###end p 44
###begin p 45
###xml 132 134 132 134 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR19">19</xref>
###xml 418 420 418 420 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR33">33</xref>
###xml 565 567 565 567 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR34">34</xref>
###xml 556 564 <span type="species:ncbi:9606">patients</span>
S-100B is located in the cytoplasm of melanoma cells. Elevated serum S100-B occurs as the result of loss of melanoma cell integrity.19 Therefore, the hypothesis that elevation of S-100B should be interpreted as a process of subclinical microscopic metastatic disease seems to be suggested by these data. Preoperative elevated S-100B could be an expression of early dissemination not detected by standard imaging tests.33 However, the tumor marker is not suitable for screening purposes or for the early detection of recurrence in the follow-up of melanoma patients.34
###end p 45
###begin p 46
###xml 272 273 272 273 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR5">5</xref>
###xml 643 645 643 645 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR33">33</xref>
###xml 646 648 646 648 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR35">35</xref>
###xml 649 651 649 651 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR37">37</xref>
###xml 1133 1135 1133 1135 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR37">37</xref>
###xml 332 340 <span type="species:ncbi:9606">patients</span>
###xml 1085 1093 <span type="species:ncbi:9606">patients</span>
The prognostic biochemical marker S-100B may be of value in the design of future trials on adjuvant systemic chemotherapy or immunotherapy. At present, LDH is the most prominent serum parameter in stage IV melanoma, and it has been included in the new AJCC staging system.5 Our study on optimally staged clinical stage III melanoma patients has now shown that preoperative S-100B elevation is associated with significantly poorer survival. These results are supported by studies from M.D. Anderson Cancer Center, Barcelona, and a recent meta-analysis and a pooled analysis of ECOG studies in high-risk surgically resected melanoma by Kirkwood.33,35-37 These studies showed that direct postoperative (baseline) S-100B is indeed a prognostic marker for disease-free survival (DFS) and overall survival (OS). Our results seem in accordance with these data, but more importantly reveal that S-100B is a prognostic marker for DFS when determined before dissection. In our study, the 2-year DFS is slightly better than in the recently published ECOG, which is explained by the fact that the patients were staged with FDG-PET and spiral CT.37 A more refined individualized risk assessment for adjuvant treatment is possible with serum marker S-100B. Therefore, S-100B could be included in future stratification research for stage III melanoma.
###end p 46
###begin p 47
###xml 55 63 <span type="species:ncbi:9606">patients</span>
###xml 230 238 <span type="species:ncbi:9606">patients</span>
###xml 281 289 <span type="species:ncbi:9606">patients</span>
###xml 439 447 <span type="species:ncbi:9606">patients</span>
In summary, preoperative elevation of S-100B levels in patients with true (clinical) stage III melanoma is associated with decreased disease-free survival and might have a prognostic clinical value in high-risk stage III melanoma patients. Therefore S-100B could be used to select patients for adjuvant systematic treatment in the stratification for new adjuvant therapeutic trials as well as to provide information for stage III melanoma patients who want to be informed about disease prognosis.
###end p 47
###begin title 48
Open Access
###end title 48
###begin p 49
This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
###end p 49
###begin title 50
References
###end title 50
###begin article-title 51
Trends in the incidence and death from cancer from 1989-2003 in The Netherlands
###end article-title 51
###begin article-title 52
Diagnosis and treatment of cutaneous melanoma: state of the art 2006
###end article-title 52
###begin article-title 53
###xml 13 21 <span type="species:ncbi:9606">patients</span>
Follow-up in patients with localised primary cutaneous melanoma
###end article-title 53
###begin article-title 54
Sentinel-node biopsy or nodal observation in melanoma
###end article-title 54
###begin article-title 55
###xml 47 55 <span type="species:ncbi:9606">patients</span>
Prognostic factors analysis of 17,600 melanoma patients. Validation of the American Joint Committee on Cancer melanoma system
###end article-title 55
###begin article-title 56
###xml 97 105 <span type="species:ncbi:9606">patients</span>
Impact of 18F fluorodeoxyglucose positron emission tomography on surgical management of melanoma patients
###end article-title 56
###begin article-title 57
###xml 76 84 <span type="species:ncbi:9606">patients</span>
Level of fluorodeoxyglucose uptake predicts risk for recurrence in melanoma patients presenting with lymph node metastases
###end article-title 57
###begin article-title 58
Serological markers for melanoma
###end article-title 58
###begin article-title 59
LDH and melanoma
###end article-title 59
###begin article-title 60
Local recurrence in malignant melanoma: long-term results of the multiinstitutional randomized surgical trial
###end article-title 60
###begin article-title 61
###xml 22 30 <span type="species:ncbi:9606">patients</span>
Prognostic factors in patients with metastatic malignant melanoma. A multivariate analysis
###end article-title 61
###begin article-title 62
Particle counting immunoassay of S100 protein in serum. Possible relevance in tumors and ischemic disorders of the central nervous system
###end article-title 62
###begin article-title 63
Clinical significance of serum S100 in metastatic malignant melanoma
###end article-title 63
###begin article-title 64
###xml 79 87 <span type="species:ncbi:9606">patients</span>
Normal values of serum S-100B predict prolonged survival for stage IV melanoma patients
###end article-title 64
###begin article-title 65
S-100 beta protein in serum, a tumor marker in malignant melanoma-current state of knowledge and clinical experience
###end article-title 65
###begin article-title 66
###xml 62 70 <span type="species:ncbi:9606">patients</span>
Radiation therapy following lymph node dissection in melanoma patients: treatment, outcome and complications
###end article-title 66
###begin article-title 67
###xml 82 90 <span type="species:ncbi:9606">patients</span>
On the release and half life of S100B protein in the peripheral blood of melanoma patients
###end article-title 67
###begin article-title 68
Serum S-100b protein as a prognostic marker in malignant cutaneous melanoma
###end article-title 68
###begin article-title 69
###xml 58 66 <span type="species:ncbi:9606">patients</span>
Serum S100beta protein as a marker of disease activity in patients with malignant melanoma
###end article-title 69
###begin article-title 70
###xml 81 89 <span type="species:ncbi:9606">patients</span>
Evaluation of S-100beta assays for the prediction of recurrence and prognosis in patients with AJCC stage I-III melanoma
###end article-title 70
###begin article-title 71
The luminescence immunoassay S-100: a sensitive test to measure circulating S-100B: its prognostic value in malignant melanoma
###end article-title 71
###begin article-title 72
Elevated serum levels of S100 and survival in metastatic malignant melanoma
###end article-title 72
###begin article-title 73
Prognostic value of serum analyses of S-100 protein beta in malignant melanoma
###end article-title 73
###begin article-title 74
Serum S-100 has prognostic significance in malignant melanoma
###end article-title 74
###begin article-title 75
Serum S100B is suitable for prediction and monitoring of response to chemoimmunotherapy in metastatic malignant melanoma
###end article-title 75
###begin article-title 76
###xml 47 55 <span type="species:ncbi:9606">patients</span>
Predictive value of serum S100B for monitoring patients with metastatic melanoma during chemotherapy and/or immunotherapy
###end article-title 76
###begin article-title 77
Serum S100-a marker for disease monitoring in metastatic melanoma
###end article-title 77
###begin article-title 78
Comparison of prognostic significance of serum 5-S-Cysteinyldopa, LDH and S-100B protein in Stage III-IV malignant melanoma
###end article-title 78
###begin article-title 79
Use of serum 5-S-CD and S-100B protein levels to monitor the clinical course of malignant melanoma
###end article-title 79
###begin article-title 80
###xml 206 214 <span type="species:ncbi:9606">patients</span>
Diagnostic value and prognostic significance of protein S-100beta, melanoma-inhibitory activity, and tyrosinase/MART-1 reverse transcription-polymerase chain reaction in the follow-up of high-risk melanoma patients
###end article-title 80
###begin article-title 81
###xml 104 112 <span type="species:ncbi:9606">patients</span>
Prognostic implications of protein S-100beta serum levels in the clinical outcome of high-risk melanoma patients
###end article-title 81
###begin article-title 82
###xml 41 49 <span type="species:ncbi:9606">patients</span>
Significance of serum S-100B in melanoma patients before and after sentinel node biopsy
###end article-title 82
###begin article-title 83
###xml 82 90 <span type="species:ncbi:9606">patients</span>
S100B levels are more accurate than LDH levels at predicting survival in melanoma patients
###end article-title 83
###begin article-title 84
###xml 39 47 <span type="species:ncbi:9606">patients</span>
The prognostic value of serum S100B in patients with cutaneous melanoma: A meta-analysis
###end article-title 84
###begin article-title 85
###xml 68 76 <span type="species:ncbi:9606">Patients</span>
Prognostic significance of serum S100B surgically resected melanoma Patients Participating in Intergroup Trial ECOG 1694
###end article-title 85
###begin article-title 86
Evaluation of new putative tumor markers for melanoma
###end article-title 86
###begin article-title 87
Serum S-100 protein: a potentially useful prognostic marker in cutaneous melanoma
###end article-title 87
###begin article-title 88
Melanoma-inhibiting activity, a novel serum marker for progression of malignant melanoma
###end article-title 88
###begin article-title 89
S-100 and NSE as serum markers in melanoma
###end article-title 89
###begin article-title 90
Clinical and prognostic relevance of serum S-100 beta protein in malignant melanoma
###end article-title 90
###begin article-title 91
Monitoring malignant melanoma with the S-100B tumour marker
###end article-title 91
###begin article-title 92
S100 protein serum levels in cutaneous malignant melanoma
###end article-title 92
###begin article-title 93
S100B protein detection in serum is a significant prognostic factor in metastatic melanoma
###end article-title 93
###begin article-title 94
###xml 37 45 <span type="species:ncbi:9606">patients</span>
Tumor markers in peripheral blood of patients with malignant melanoma: multimarker RT-PCR versus a luminoimmunometric assay for S-100
###end article-title 94
###begin article-title 95
###xml 105 113 <span type="species:ncbi:9606">patients</span>
S-100 protein in peripheral blood: a marker for melanoma metastases: a prospective 2-center study of 570 patients with melanoma
###end article-title 95
###begin article-title 96
Serum S100B protein and stage of cutaneous melanoma: a prospective study
###end article-title 96
###begin article-title 97
The value of serum S-100beta and interleukins as tumour markers in advanced melanoma
###end article-title 97
###begin article-title 98
###xml 85 93 <span type="species:ncbi:9606">patients</span>
Rising levels of serum S100 protein precede other evidence of disease progression in patients with malignant melanoma
###end article-title 98
###begin article-title 99
Comparison of two prognostic markers for malignant melanoma: MIA and S100 beta
###end article-title 99
###begin article-title 100
###xml 106 114 <span type="species:ncbi:9606">patients</span>
Soluble HLA-DR is a potent predictive indicator of disease progression in serum from early-stage melanoma patients
###end article-title 100
###begin article-title 101
Prognostic value of serum S-100B in malignant melanoma
###end article-title 101
###begin article-title 102
Serum markers for melanoma
###end article-title 102
###begin article-title 103
###xml 76 84 <span type="species:ncbi:9606">patients</span>
Tyrosinase messenger RNA in peripheral blood is related to poor survival in patients with metastatic melanoma following interleukin-2-based immunotherapy
###end article-title 103
###begin article-title 104
Melanoma inhibiting activity protein (MIA), beta-2 microglobulin and lactate dehydrogenase (LDH) in metastatic melanoma
###end article-title 104
###begin p 105
An erratum to this article can be found at
###end p 105

